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Abstract
Photoassisted diversity-oriented synthesis holds great promise in its ability to
provide rapid access to complex and diverse molecular scaffolds. As it stands, while
photochemical techniques have this potential, their implementation in the field of
synthetic organic chemistry is very limited. The main goal of this project was to utilize
photochemically assisted techniques in the synthesis of a variety of novel
polyheterocycles.
Initially, we explored the how the strain installed in these polycycles could be
harnessed to trigger cationic rearrangements in the framework of the system. This was
achieved via the high yield and rapid assembly of a highly strained system containing two
oxetanes. This bis oxetane was derived from a compound containing carbonyl groups
endo- to two respective bicyclic olefins which was assembled via a simple Diels-Alder
step. The oxetanes were formed in a Paternò-Büchi reaction via excited-state chemistry.
The protolytic ring-opening of this bis-oxetane compound afforded two highly unusual
polycyclic products that both result from rather complex mechanisms which are proposed
in this work. In addition, we were able to elaborate on this rapid Diels-Alder assembly
motif by designing a double-tandem [4+2][2+2][4+2][2+2] synthetic sequence which
culminates in a complex scaffold containing an oxetane. When subjected to acidolysis,
this oxetane affords a complex polycycle with rigidly held pendants rich in heteroatoms.

ii

We then intended to study how a bicyclic olefin which also possessed endocarbonyl groups would perform during irradiation when the length of the tether to the
bicyclic system was lengthened. This lengthened tether allowed flexibility in the
regiochemistry of the Paternò-Büchi cycloaddition. The regiochemistry was also able to
be controlled by the introduction of a methyl group in the tether. The protolytic opening
of the two different oxetanes gave polyheterocyclic products with completely different
scaffolds that both demonstrate a great increase in complexity of structure relative to the
quite simple starting materials.
In a departure from Paternò-Büchi, our next design strategies focused on the
photo-generation of azaxylylenes via excited-state intramolecular proton transfer. We
tethered these azaxylylenes to unsaturated pendants in the hopes that the short-lived
intermediate would undergo cycloaddition with these pendants. In this endeavor, we were
able to observe both [4+4] and [4+2] cycloadditions, depending on the type of pendant
used. We were able to diversify this system by utilizing both carbonyls and imines as the
proton abstraction agents, by using thiophene and furan as the unsaturated pendant, and
by tethering the pendant to the carbonyl “half” and the aniline “half” of the
photoprecursor—demonstrating the tolerance that this system has for a large range of
modifications.
With the optimization of these methodologies, we aim to pave the way for the
incorporation of photochemistry into the toolbox of synthetic chemists by demonstrating
the molecular diversity that these techniques allow.
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Chapter 1: Introduction
The utilization of photochemical techniques in synthetic organic chemistry can
allow access to strained polycyclic structures whose framework would not easily be
accessible via ground state chemistry. However, with very few exceptions,1
photochemical techniques are deeply underutilized in synthetic schemes, despite the
concise pathways they can provide to complex targets and often privileged carbon
scaffolds. Even rarer is the use of photochemistry in diversity-oriented synthesis.
Photoassisted Syntheses
Perhaps the most commonly applied photochemical step employed in syntheses is
[2+2] cycloaddition, as it is the most convenient route to the formation of 4-membered
rings. This pericyclic reaction is forbidden in the ground state, but is possible when one
of the -systems is excited. This relationship becomes clear when one considers the
frontier molecular orbital theory, an approach first suggested by Kenichi Fukui in 1952.2
He posited that when trying to predict the reactivity of a -system, one can assume that
the electrons in the highest energy -orbitals (i.e.; HOMO), which he dubbed frontier
electrons, determine the overall electron density, and thus reactivity of the species. This
concept was simultaneously developed by Robert B. Woodward and Roald Hoffmann* in
their seminal publications Stereochemistry of Electrocyclic Reactions (1965)3a and
Conservation of Orbital Symmetry (1968),3b the content of which outlines what we now
*

Hoffmann and Fukui were both awarded the Nobel Prize for Chemistry in 1981 for their study in this
area; Woodward received the prize in 1965 for his work in total synthesis.
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call the Woodward-Hoffmann rules. These rules predict the reactivity in pericyclic
reactions based on the orbital symmetry in the -systems in either the ground or excited
states.
Regarding [2+2] cycloaddition, Figure 1.1 demonstrates the application of these
rules. In this frontier molecular orbital approach, one must consider the symmetry of the
HOMO of one molecule with the LUMO of the other. If the orbital symmetry is
conducive to bonding interactions, the reaction is allowed. In the example in Figure 1.1,
the ground state chemistry of a [2+2] reaction gives an antibonding interaction upon the
approach of the orbitals. In the excited state, however, the HOMO and LUMO give only
bonding interactions; thus this reaction is allowed in the excited state.

Figure 1.1: FMO Approach to [2+2] cycloaddition

In a -system, a cycloaddition reaction may only take place when the orbital
symmetry of the HOMO and LUMO are conducive to a bonding interaction at the
terminal orbitals of each molecule. This approach applied to a [2+2] cycloaddition

2

elucidates why it proceeds in photochemical conditions, as the barrier is too high in the
ground state.†
A notable example of an elegant [2+2] reaction by Winkler et. al. in 2002 is in the
first reported total synthesis of ingenol,4a a lead compound related to a anticancerous
terpenoid drug approved by the FDA called Picato®, or ingenol mebutate. Currently, the
major source for ingenol mebutate is through direct extraction from Euphorbia peplus
(aka milkweed) which yields 1.1 mg of ingenol mebutate from every kilogram of E.
peplus.4b,c In some cases, it is synthesized from ingenol, which can be extracted in a yield
of 275 mg/kg of raw plant material (the dried seeds of E. lathryis).4d In comparison, the
natural product artemisinin is the most commonly prescribed antimalarial on the market
and is currently sourced by direct extract from raw plant material (Artemisia annua) at 5
g/kg of dry leaves.4e Thus, it follows that a better path to the synthesis of ingenol would
be valuable tool for the pharmaceutical industry.
In Winkler’s synthetic sequence, a [2+2] cycloaddition is employed in order to
install the skeletal framework necessary in 2, which sets it up for the further
transformation into the [4.4.1] bicyclic framework in the final product, ingenol. While
this synthesis was groundbreaking in that it was the first total synthesis, it was over 43
steps with an overall yield of less than 0.01%. However, as Winkler points out, the
photoaddition and fragmentation approach establishes the unique trans-bridgehead
stereochemistry in the [4.4.1] skeleton, a challenging feat. It is also worth mentioning that
while a higher-yielding non-photochemical total synthesis of ingenol has since been

†

It must be noted that this generalization is true for suprafacial approaches only. The opposite holds for
antarafacial interactions, like in the cycloadditions of alkenes to ketenes.
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reported,4e

the

photochemical

step

shown

in

Scheme

1.1

installs

a

tricyclo[6.2.0.02,6]decane core, a motif present in a variety of terpenoid natural
products,4f-h which supports the potential for synthetic utility of this method

.

Scheme 1.1: Photochemical [2+2] in Ingenol synthesis4a

Scheme 1.2: Photoassisted synthesis of three antibacterial phytoalexins

Another example of a [2+2] step was reported in 2006 by Srikrishna and
Ramasatry in their enantioselective total synthesis of a variety of phytoalexins, a family
4

of powerful antibacterial compounds derived from an isolate of tobacco leaves.5a This
sequence began from the derivatization of (R)-(-)-carvone (Scheme 1.2), a relatively
inexpensive commercially available starting material. After performing the cycloaddition
to give 3, the photoproduct was then derivatized to form 4, (+)-solanascone and 5, (+)dehydrosolanascone. With the success of this approach, they went on to synthesize a
variety of further derivatives, including the natural product (+)-

-hydroxysolanascone,

6.5b
Cyclobutanes can also be installed via the DeMayo reaction, in which the enol
tautomer of a 1,3-dicarbonyl is captured by a [2+2] cycloaddition. The subsequent retroaldol fragmentation functionally serves to insert the alkene (now unsaturated) between
the two carbonyls. Scheme 1.3 shows a creative example of such a reaction employed by
Minter and Winslow in 2004 in the synthesis of a galanthane skeleton which is contained
in (-)-lycorine,6 a potent toxin found in daffodil bulbs. The synthesis of this framework is
achieved via the intramolecular [2+2] cycloaddition of the enol tautomer to the
isoquinolinone in 7 to form 8, which rapidly rearranges to 9. Treating 9 to basic
piperidine conditions gives 10, a lead toward the synthesis of (-)-lycorine. This toxic
compound and its relatives have proven to have anticancer activity in a thorough
structure-activity relationship (SAR) study and holds promise as a lead compound against
a variety of metastatic cancers,7 which further emphasizes the practicality of a highyielding approach to this scaffold.

5

Scheme 1.3: DeMayo reaction in galanthane synthesis6

In the discussion of [2+2] cycloaddition, one would be remiss to neglect the
Paternò-Büchi reaction—the cycloaddition of a carbonyl to an olefin to form an oxetane,
a 4-membered cyclic ether. Notable in the Paternò-Büchi reaction scheme is the potential
for intersystem crossing (ISC) of the singlet n* excited state to form the triplet [the
notation for these excited states are

1

*) and

3

*) respectively]. Howard

Zimmerman first proposed a non-concerted mechanism for this reaction in which a 1,4diradical is formed, with the stability of the diradical generally governing the major
product.8 When the diradical intermediate proceeds in the triplet manifold, the final
closure into the oxetane ring is forbidden and must first undergo ISC into the singlet state
with the assistance of spin-orbit coupling, which also contributes to the stereochemical
control.9

6

Greaney et. al. utilized the Paternò-Büchi reaction in a synthesis of the core
structure of Merrilactone A (see Scheme 1.4), which is a natural product reported to act
as a neurotropic agent.10 While this particular research group had the natural target in
mind, one can’t help but marvel at the dramatic growth in molecular complexity in this
single step from 11 to 12: from one stereocenter to four with perfect diastereoselectivity,
the dramatic change in the polycyclic framework, and the possibility for the utilization of
diversity inputs to explore the SAR of its natural product analog are all exciting features
available with the assistance of this single photochemical step.

Scheme 1.4: Photochemical route to the Merrilactone A framework10

Excited-state electrocyclic ring-closures are also an important way in which
photochemistry is utilized to access difficult scaffolds. Similar to cycloadditions,
photocyclizations in the singlet state are governed by the Woodward-Hoffmann rules.
However, rather than considering the HOMO and LUMO frontier orbitals of two separate
molecules, one examines the symmetry of the terminal orbitals in the HOMO of a system. The orbitals rotate in such a way that they form a bonding (rather than
antibonding) interaction—and the molecular orbitals reveal if this proceeds via a
conrotatory or disrotatory process, as demonstrated in Figure 1.2.

7

Figure 1.2: Conrotatory vs. disrotatory in 4 electrocyclization

The generalization of this rule is that if there is an even number of electron pairs
involved in the pericyclic reaction, the cyclization will proceed in a conrotatory fashion
under thermal conditions. All other conditions (odd number of electron pairs, disrotatory,
or photochemical conditions) can be inferred from this statement. The direction of
rotation allowed in the given conditions determines the stereochemical configuration of
the product (when applicable).

8

Figure 1.3 shows a series of examples in which a 6 photocyclization is
employed to assemble natural products. The arrows in the figure indicate the sigma bond
which is formed in the cyclization step. Note that because this is an odd number of
electron pairs and the conditions are photochemical, the reaction proceeds in a
conrotatory fashion. However, because these examples are all subsequently oxidized
from the cyclohexadiene intermediate to the aromatic final product, this nuance is not
obvious.

Figure 1.3: 6 photocyclization products of dictyodendrin B (13), 11a (+)-rebeccamycin
(14),11b the algycon of staurosporine (15),11c ellipticine (16),11d and methoxatin (17)11e

This type of photocyclization is not limited to olefinic scaffolds. The
6

is

outlined in Scheme 1.5 which was implemented by Rigby et. al. in the total syntheses of
(+)- narciclasine and (+)-pancrastatin.12a This cyclization is thought to proceed via the
zwitterionic tautomer (19) of the amide (18). The photocyclization followed by a
9

suprafacial [1,5] hydride shift to give 21. The bulky stereogenic center adjacent to the system affords diastereoselective control in the formation of 20, which is crucial to the
synthesis. Unique in this scheme is the utilization of the photoproduct as a common
precursor for both natural products. (+)-Pancrastatin is of particular interest due to its
antineoplastic activity against ovarian sarcoma and lymphocytic leukemia.12b It is also
suggested that (+)-narciclasine warrants further investigation of activity as it is thought to
act by disrupting protein biosynthesis in eukaryotes, though the mechanism is currently
unclear.12c,d

Scheme 1.5: 6 photocyclization of an enamide in natural product synthesis12

While photochemical cycloaddition and cyclization reactions serve to install (or
fragment in the case of retro-reactions) a target framework, photochemical
10

rearrangements often serve to “scramble” an existing scaffold. Arguably, this contributes
to the idea that photochemistry is exotic. One such reaction is the di--methane
rearrangement. This is a reaction in which two -systems insulated by an sp3 carbon are
excited to form a diradical which can rearrange, as in Scheme 1.6. When one of the systems is a carbonyl, this is called an oxa-di--methane rearrangement.

Scheme 1.6: Oxa-di--methane rearrangement

Demuth and Hinsken employed such a rearrangement in their synthesis of (-)silphiperfol-6-en-5-one (22; see Scheme 1.7) in a rather congested system with
reasonably good yield.13

Scheme 1.7: Photoassisted synthesis of (-)-silphiperfol-6-en-5-one13

In addition to using light as a reagent in photochemical transformations,
irradiation conditions also provide the opportunity to generate singlet oxygen, which can
complex with alkenes to form an exciplex and participate in an ene reaction (see Scheme
1.8). The stepwise mechanism for such an interaction, its rates, and steric control were
11

studied thoroughly by Clennan.14 The addition of oxygen in this reaction is often facially
selective depending on the steric environment of the starting alkene. It is appealing to be
able to use light and atmospheric oxygen as a means to selectively introduce heteroatoms
into a compound which might be sensitive to harsher oxidation conditions.

Scheme 1.8: Photo-oxidation of alkenes

While this is not a comprehensive list of the photochemical reactions utilized in
syntheses, exploration of the literature makes it clear that we have barely scratched the
surface of the potential that excited state chemistry holds as a tool in synthesis for both
the transformation and assembly of unique scaffolds.

Diversity-Oriented Synthesis
Targeted synthesis is deeply rooted in the history of organic chemistry.
Commonly, the “targets” are natural compounds which present the researcher with a
problem-solving puzzle of trying to synthesize a complex target from simpler starting
materials. This process is called retrosynthetic analysis15 and has proven to be immensely
useful at chipping away at the synthesis of many targets of value in medicinal
chemistry.16 In the previous section, there were several examples of the utilization of a

12

photochemical step in the synthetic sequences of (or toward) the synthesis of many such
natural compounds and targets.
While targeted synthesis is a “laser-focused” approach to compounds, diversityoriented synthesis (DOS) can comparatively be considered a “shotgun approach.” The
goal is aimed at collecting a large number of molecules that have a broad range of
structural diversity and complexity. This ideology has the potential to work symbiotically
with the characterization of the human genome. Hopkins and Groom discuss this topic
and use the term “druggable genome” to emphasize that half of the proteins expressed by
the human genome are not functionally classified—and how vast the “market” for drug
leads really is.17 The National Cancer Institute has programs focused on collecting
genomic information on such uncharacterized proteins and making it widely available.
With the collective efforts of small molecule chemists as well as the information made
available by the characterization of these proteins, Hopkins and Groom posit that these
“druggable” domains should be the focus for those in the market for new drugs.
However, as Schreiber and Strausberg point out,18 there is still a large gap
between having this genomic information and knowing what to do with it. They suggest
that small molecule probes are the key to narrowing the gaps in these uncharacterized
proteins—their function, binding pockets, native binding targets, etc.—and that the
fastest way to achieving libraries of these probes is via a DOS approach.18 Highthroughput screening combined with a diversity-oriented approach to drug targets could
saturate the pharmaceutical industry with “hits” for druggable targets (i.e., proteins whose
function can be modulated with drugs). In addition to rapidly identifying these hits, a
13

DOS approach could allow for a more rapid assessment of structure-activity relationships
and elucidating the functionality of these uncharacterized proteins. For example, if a
member of a library of molecules, let us call it Mol-A, is found to be an inhibitor of a
kinase, Kin-A, one could screen the activity changes that result in Kin-A from any
number of other members from the same library in order to see how the diversity inputs
generated from the DOS approach modulate the protein function differently. Rather than
exploring knockout genes or synthesizing analogs of Mol-A one-by-one, the DOSapproach provides rapid access to iterations of this lead compound. Not only could these
small molecule probes serve as drug leads, but their function in these library screenings
could serve to provide a deeper understanding of cell circuitry or disease biology by
simply modulating a biological system in any way—if not activating or deactivating the
mechanisms involved in diseases.
Because of this broad horizon in the context of high-throughput screening, DOS is
a “fertile ground for chemists” in which the goal of new drug discovery holds great
promise for connections to biology and medicine.19 Even in the spectrum of proteins with
known function and characterized binding targets, the potential that high-throughput
screening can offer for revealing new binding sites holds great promise. It is for this
reason that there is a call to arms for small drug-like molecules—the structures of which
can only be limited by our imagination.
Combinatorial techniques introduced in the 1990s began to address these demands
in the synthesis of vast libraries of non-peptide organic compounds. Efficient drug
discovery, lead optimization, and structure-activity studies were major contributions
14

provided by combinatorial chemistry. But even with this approach, Oh and Park posit that
combinatorial chemistry “has not led to a notable increase in the number of new chemical
entities…approved by the United States Food and Drug Administration.”20 As such, they
argue that conventional combinatorial techniques tend to be iterative upon a small
number of core skeletons and are unable to populate the chemical space which is relevant
to applications in chemical biology. According to their line of thinking, proliferating
libraries of compounds should not be iterative for its own sake, but rather focused on
privileged core frameworks which have the greatest potential for biological impact. It is
hoped that this focus will give rise to compounds rich in structural diversity but still
having “drug-like” properties.
These are among the reasons that the field of DOS is rapidly growing. There is
not only a need for the synthesis of a large number of valuable molecules, but for the
development and optimization of methodologies which tolerate a variety of diversity
inputs and provide a rapid growth in complexity. It is the hope that with such
methodologies developed, libraries of compounds can be achieved rapidly, efficiently,
and then screened for activity against any number of vectors.

Polyheterocycles
With the emerging focus on the characterization of gene and protein functions
since the characterization of the human genome, biomedical research groups have begun
to turn their focus to the utilization of small-molecule modulators in the
control/manipulation of gene products. This growing field of chemical biology has the
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core aims of identifying these small molecules which can perturb biological systems and
use these agents to study the activation or deactivation of gene products by their direct or
indirect interactions. This culminates in a growing demand for the synthesis of small,
drug-like compounds which cover a broad range of molecular diversity.
Traditionally, medicinal chemists have turned to natural products as they certainly
qualify for their molecular diversity. Natural products and their analogs have been widely
successful as therapeutic agents, with 60% of anticancer and 75% of antibiotic agents in
the pharmaceutical market being natural extracts or derived from such.21 A common
theme among the family of natural targets as drug leads is that they are “anti”—
anticancerous, antiviral, antitumor, antihelmintic, antifungal. This is because the function
these natural products serve to their original hosts is in the protection from pathogens.
Often, they do their job too well and kill everything—including an unreasonable amount
of healthy human cells—making them unviable as drug leads. However, in disease states
whose treatment is less interdependent on cytotoxicity (such as diabetes, depression,
osteoporosis, etc.), natural products tend to be far less effective.21 Natural products also
have significant hurdles in the endeavor to scale-up their production for either direct use
or structural modification.
Waldmann et. al. claim that a wholly unbiased DOS approach to complex small
molecules is not as important as an approach which has biologically validated molecular
frameworks that are either derivatives of natural products or which contain motifs present
in natural products.22 From this idea, it is argued that a diversity-oriented sequence aimed
at rigid, polyheterocyclic substructures has a greater potential for identifying novel
therapeutic agents and modulators.21 While this focus on these privileged structures is not
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quite in keeping with the true intent of unbiased DOS, it is important to address the
demand for maximizing molecular diversity while still keeping within the framework of
what will more likely be relevant in biological and pharmacological applications. To this
end, the research within this work attempts to combine these concepts—the utilization of
photochemical techniques to access privileged polycyclic and polyheterocyclic structures
which are diverse, structurally complex, and via methodologies that can be augmented
with diversity inputs.
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Chapter 2: Installing and Harnessing Strain in Oxetanes
Rearrangement of a bis-Oxetane
Introduction
In the attempt to access frameworks for biologically active natural products,
Rawal employed the Paternò–Büchi reaction in endo-acylnorbornenes which are readily
accessed from Diels-Alder reactions of cyclic dienes with vinyl ketones (Scheme 2.1).23
The oxetane product (and its transformations) shows remarkable growth in molecular
complexity from such simple starting materials and is demonstrative of the appeal for
such a synthetic sequence.

The subsequent ring opening, oxidation, and radical

fragmentation of these photoproducts resulted in the synthesis of di- and triquinanes, a
motif that frequently occurs in natural products.

Scheme 2.1: Rawal’s approach to diquinanes23

In 1973, Jones observed that oxetanes can be converted pyrolytically via
cycloreversion to an alternative pair of an alkene and an aldehyde, constituting a
carbonyl-olefin metathesis (Scheme 2.2).24 Griesbeck proposed an electron transfer
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mechanism for a similar reaction in 2006.25 While these pyrolytic transformations have
great synthetic potential, the harsh conditions under which they occur preclude their
application to more delicate compounds.

Scheme 2.2: Carbonyl-olefin metathesis

Sauers’ reseach on endo-norbornenyl systems combines these two concepts of an
intramolecular Paternò–Büchi reaction to install an oxetane followed by carbonyl-olefin
metathesis

(henceforth

oxametathesis)

in

5-norbornenylacetone

and

5-

norbornenylacetaldehyde and the subsequent acid-catalyzed cleavage of the installed
oxetane ring, shown in Scheme 2.3.25 This intramolecular transformation results in a
polycycle with a completely new topology relative to the starting material.

Scheme 2.3: Sauers’ oxametathesis25

Following his extensive research on these systems, Sauers’ attempt to apply this
method to more strained polycycles came to a dead end when the endo-carbonyl was part
of a cyclic ketone. This fused norbornene derivative containing a tricyclo[5.2.1.02,6] core
(Scheme 2.4) was incapable of undergoing the Paternò-Büchi cycloaddition that had been
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observed in so many other analogs. Rather, tricyclo[5.2.1.04,9]undecan-5-one was
produced instead of the expected oxetane.26c

Scheme 2.4: Unexpected product26c

It appears that in such a highly strained and rigid tricycle, the π-orbital of the
carbonyl group simply cannot reach the double bond to complete the Paternò-Büchi
cycloaddition. Instead, the excited carbonyl performs an electron transfer to the double
bond (I), followed by alpha-H abstraction by the double bond (II). Tautomerization of
the enol radical (III), and subsequent collapse of the 1,5-diradical (IV) results in the
isolated product.

Scheme 2.5: Proposed mechanism

Due to this failure in the formation of the desired oxetane photoproduct, there
were no subsequent fruitful studies in these fused endo-carbonyl polycycles until in 1977
when Paddon-Row found a competing Paternò-Büchi side reaction in the attempts to
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research an all-carbon [2+2] photocyclization in a hemicyclone-benzoquinone adduct.27a
This finding was later confirmed by Coxon.27b
Roman A. Valiulin studied the photoreactivity of these fused ring systems,
finding both computationally and experimentally that inceasing the ring size of either
“half” of the fused ring system (i.e., the ketone half or the bicyclo half), the
photoreactivity could be restored. Density Functional Theory (DFT) calculations at the
B3LYP/6-311+G(d,p) level confirmed that the target oxetane relaxes by as much as 11
kcal/mol when its cyclopentyl moiety is expanded by a single methylene group,
suggesting that the Diels-Alder adducts of six membered and larger cycloalkenones can
be Paternò-Büchi photoreactive.27
In collaboration with Roman A. Valiulin, a system was designed which was
capable of performing two intramolecular Paternò-Büchi cycloaddition reactions. The
Diels-Alder adducts of benzoquinone with two molecules of cyclopentadiene and
cyclohexadiene were known,29 but their photochemistry had not been studied.

Scheme 2.6: bis-Diels Alder adducts of benzoquinone

While the irradiation of the bis-adduct with cyclopentadiene (1a) was not
photoreactive, the cyclohexadiene analog (2a) proved to be a promising lead. Upon
irradiation, it formed a bis-oxetane polycycle (95% by NMR) via the mono-oxetane
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intermediate (3a) observed during the irradiation (see Scheme 2.7). The structure of the
bis-oxetane (4a) was proved by Roman A. Valiulin via X-ray crystallography.
It then became our goal to explore the oxemetathetic transformations capable in
such a highly strained polycyclic structure.

Scheme 2.7: Irradiation of 2a

Results and Discussion
For this bis-oxetane, the interest for my research was supremely in the deep
cationic rearrangement upon its protolytic ring opening in the presence of HCl. These
rearrangements are only possible due to the high amount of strain installed in the
photochemical Paternò-Büchi step. This strain is installed, then harnessed in order to
produce complex polycyclic scaffolds. The minor products shown in Scheme 2.8 (5a
and 6a; both less than 5% in yield) gave a unique insight into the mechanistic capabilities
of this highly strained rigid polycycle.
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Scheme 2.8: Two minor products of oxametathesis‡

Our proposed mechanism for the formation of 5a (see Scheme 2.9) begins with
protolytic ring opening of one oxetane ring, which furnishes carbocation A1 that
rearranges via 1,2-alkyl migration to form A2. The resulting electrophilic center is
captured by chloride to form A3. Acid promoted ring opening of the second oxetane
gives A4, which then is deprotonated in order to cyclize into the key intermediate, A5—
containing a cyclopropyl ring. In Dr. Andrei Kutateladze’s force field estmate, the
cyclopropyl intermediate A5 is about 20 kcal/mol lower in energy than its oxetane
precursor, A3 (deprotonated). The subsequent acid-catalyzed Grob fragmentation gives
the cis-fused alkene A6, which equilibrates via its enol intermediate into 5a, which has a
trans configuration and is calculated to be 1.5 kcal/mol more stable that A6.§

‡

This research was done in collaboration with Roman A. Valiulin, who characterized 2a-1, 2a-2, and 2a-3
in Scheme 2.8
§

See ref [28] and the SI therein for details regarding computational data.
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Scheme 2.9: Mechanism for the formation of 5a

The mechanism for the formation of 6a is far more complex. We propose that the
rearrangement begins with an acid-catalyzed cycloreversion of an oxetane ring as shown
in Scheme 2.10. This proposed cycloreversion is supported by the fact that one of the
products recovered from the acidolysis is the starting alkene 2a. This is followed by a
1,2-hydride shift to form B2 via a retro-pinacol rearrangement. A second 1,2-hydride
shift occurs (B3) followed by a Grob fragmentation to form B4. Protolytic ring opening
then proceeds with the capture of the carbocation by the formyl group, which is then
hydrolyzed into the hemiacetal B7. The subsequent intramolecular electrophilic conjugate
addition to the alkene in the bicyclo[2.2.2]diene gives 6a.
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Scheme 2.10: Mechanism for the formation of 6a

The beauty of this system lies in its rapid assembly and clean photoreactivity,
resulting in a remarkable increase in complexity from the very simple and inexpensive
starting materials (benzoquinone and cyclohexadiene). The utilization of a photochemical
step in this modular synthetic sequence can give access to a unique highly strained C2symmetric structure. Harvesting the strain in this bis-oxetane allowed for cationic
rearrangements upon its protolytic ring opening, resulting in novel carbocyclic scaffolds.
These products are a spectacular example of how photochemistry combined with
conventional synthetic techniques can give expeditious access to highly complex
polycyclic scaffolds. While the syntheses of some of these interesting polyheterocycles is
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not quite preparative due to the low yield in the acidolysis step, the scheme gives a good
deal of insight into the deep skeletal rearrangements a strained scaffold can do.

Experimental Procedures and Data
Common solvents were purchased from Pharmco Aaper and used directly, except
for THF—which was refluxed over and distilled from potassium benzophenone ketyl
prior to use—and hexane—which was distilled over calcium hydride. Common reagents
were purchased from Sigma Aldrich, Acros, or TCI America and used without additional
purification, unless indicated otherwise. NMR spectra were recorded at 25 oC on a Bruker
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an
internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker
APEX II instrument. High resolution mass spectra were obtained on the MDS
SCIEX/Applied Biosystems API QSTARTM Pulsar i Hybrid LC/MS/MS System mass
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at
Boulder. For the synthetic details,

1

H,

13

C, COSY NMR spectra see supporting

information.27

1SR, 2RS, 4RS, 5SR, 8RS, 9SR,
11SR, 12RS-pentacyclo[10.2.2.25,8.02,11.04,9] octadeca-6,13-diene-3,10-dione (2a): A
solution of 4.00 g of 1,4-benzoquinone (37.0 mmol) and 8.90 g of 1,3-cyclohexadiene
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(111.0 mmol) in 20 mL of 1,2-dichlorobenzene was heated in a Pyrex screw-cap pressure
tube at 135-150oC for 24 h. The solvent was removed on a high vacuum pump and the
crude reaction mixture was then recrystallized from hot CH3CN: 9.71 g (98%). 1H NMR
(400 MHz, CDCl3) δ = 6.30 (m, 4H), 2.96 (m, 4H), 2.76 (m, 4H), 1.55-1.48 (m, 4H),
1.30-1.25 (m, 4H). 13C NMR (400 MHz, CDCl3) δ = 210.9, 134.0, 53.8, 32.6, 24.7.

(4a) A solution of 3.00 g of
2a (11.2 mmol) in 2 L of CH3CN was irradiated in a quartz reaction vessel in a Rayonet
reactor equipped with RPR-3000 UV lamps (a broadband 250-350 nm UV source with
peak emission at 300 nm) for 60 hours. Irradiation resulted in nearly quantitative
conversion to 4a (90% by NMR), which was used without further purification. For
characterization, oxetanes partially survived flash chromatography on a silica gel column
pre-treated with 2 mL of pyridine with an eluent of hexane – EtOAc, 20:1→5:1.: (> 95%
by NMR). 1H NMR (400 MHz, CDCl3) δ = 4.39 (m, 1H), 2.86 (dddd, J = 5.5, 3.6, 1.8,
1.8 Hz, 1H), 2.43 (d, J = 2.1 Hz, 1H), 2.38 (m, 1H), 2.17-2.14 (m, 1H) overlaps with 2.13
(dddd, J = 7.8, 4.1, 2.0, 2.0 Hz, 1H), 1.84 (dddd, J = 13.9, 10.1, 10.1, 2.3 Hz, 1H), 1.70
(ddd, J = 3.7, 10.0, 13.7 Hz, 1H), 1.59 (ddd, J = 13.3, 9.7, 4.0 Hz, 1H), 1.18 (dddd, J =
13.1, 10.0, 10.0, 1.9 Hz, 1H).
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C NMR (400 MHz, CDCl3) δ = 99.7, 83.6, 54.8, 46.0,

44.5, 38.4, 34.8, 23.2, 17.8. This characterization was completed by Roman A.
Valiulin.
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Acidolysis: To a solution of 1.18 g (4.4 mmol) oxetane 4a in 100 mL acetonitrile, 4.4 mL
4M, HCl (solution in dioxane) was added. This was allowed to stir for 10 min at ambient
temperature before quenching with saturated sodium bicarbonate (2 x 20 mL), extracting
with dichloromethane (2 x 20 mL). The organic layers were combined and dried over
anhydrous sodium sulfate before concentrating to remove the solvent. The residue was
purified on a silica gel column using hexane–ethyl acetate (10:1, then 5:1, then the
column was washed with ethanol).

(5a): 32 mg, 2.4%

(pure

recovery). 1H NMR (400 MHz, CDCl3) δ = 5.98 (dd, J = 5.8, 2.7 Hz, 1H), 5.94 (dd, J =
5.7, 2.7 Hz, 1H), 3.59 (d, J = 2.1 Hz, 1H), 3.13 (ddd, J = 5.3, 2.5, 2.5 Hz, 1H), 2.85 (m,
1H), 2.80 (s, 1OH), 3.67 (m, 1H) overlaps with 2.66-2.61 (m, 1H), 2.32-2.29 (m, 2H),
2.15-2.06 (m, 2H), 2.02 (dddd, J = 10.5, 5.4, 5.4, 2.1 Hz, 1H), 1.91-1.85 (m, 2H), 1.82
(m, 1H), 1.63-1.55 (m, 3H), 1.29 (ddd, J = 13.3, 11.0, 2.3 Hz, 1H), 1.22 (d, J = 10.3 Hz,
1H).
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C NMR (400 MHz, CDCl3) δ = 213.7, 133.9, 132.5, 87.6, 66.6, 59.4, 59.4, 52.4,

49.3, 45.0, 44.9, 42.7, 42.6, 40.3, 38.5, 32.2, 30.3, 23.7. HRMS (ESI) calcd for
C18H21ClNaO2+ (MNa+) 327.1122, found 327.1112.
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(6a):
recovery).

1

20

mg,

1.1%

(pure

H NMR (400 MHz, CDCl3) δ = 6.39 (ddd, J = 8.0, 6.6, 1.2 Hz, 1H), 6.25

(ddd, J = 8.0, 6.5, 1.4 Hz, 1H), 5.25 (d, J = 4.9 Hz, 1H), 3.73 (d, J = 3.1 Hz, 1H), 2.68
(m, 1H), 2.63 (m, 1H), 2.54 (d, J = 5.4 Hz, 1H), 2.46 (m, 1H) overlaps with 2.42 (dddd, J
= 6.3, 2.1, 2.1, 2.1 Hz, 1H), 2.17 (dddd, J = 12.5, 9.9, 4.5, 2.4 Hz, 1H) overlaps with 2.12
(d, J = 2.4 Hz, 1H), 2.04 (m, 1H), 1.96 (dd, J = 13.7, 1.8 Hz, 1H) overlaps with 1.94-1.91
(m, 1H), 1.65 (ddd, J = 13.7, 3.5, 3.5 Hz, 1H), 1.59-1.51 (m, 3H) overlaps with 1.51-1.38
(m, 2H), 1.17 (ddddd, J = 11.9, 11.9, 4.3, 2.9, 2.9 Hz, 1H), 1.03 (dddd, J = 12.4, 12.4,
3.8, 3.8 Hz, 1H). 13C NMR (400 MHz, CDCl3) δ = 134.5, 132.6, 101.8, 99.2, 79.6, 78.9,
48.5, 48.2, 43.`, 40.0, 38.8, 37.2, 32.7, 30.4, 25.2, 22.8, 22.1, 18.4. HRMS (ESI) calcd for
C18H22NaO3+ (MNa+) 309.1461, found 309.1459.
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Double-Tandem Sequence of 1,4-Naphthoquinone
Introduction
Another way we endeavored to introduce diversity into our armory of
photosynthetic sequences was to utilize 1,4-naphthoquinone in reaction with cyclic
dienes. Filipescu and Kushner independently showed that the Diels-Alder adduct of
cyclopentadiene with 1,4-naphthoquinone (7a) is known to undergo intramolecular
alkene-arene [2+2] cycloaddition. The product of this reaction (8a) also contains a diene
whose subsequent Diels-Alder reaction with a dienophile is known to be facially
selective.30 Coxon, Marchand, and others studied the facial selectivity of Diels-Alder
additions to 8a, showing that the attack of unsaturated dienophiles occurs on the face
nearer to the carbonyl groups.31 The scaffold resulting from these reactions is shown in
Scheme 2.11.

Scheme 2.11: Cycloaddition sequence

We employed this facially selective reaction to install an aroyl chromophore
capable of undergoing a photochemical Paternò-Büchi reaction with the neighboring

30

olefin, furnishing an oxetane which can undergo further transformation via
oxametathesis.
Results and Discussion
This high-yielding reaction sequence comprises a double-tandem approach which
combines both ground state chemistry and two photochemical cycloadditions,
culminating in a [4+2]◦[2+2]◦[4+2]◦[2+2] scheme. As it was mentioned before, the DielsAlder adduct of 1,4-naphthoquinone with cyclopentadiene is known to undergo the
alkene-arene intramolecular [2+2] photocycloaddition. Our attempt to do the same with
the cyclohexadiene analog did not undergo the desired “cage” reaction, but instead led to
endo/exo isomerization, which is precedented.34 However, the adduct derived from
cyclopentadiene (99%, 7a), provided the diene (8a) in good yield (Scheme 2.12). We
then subjected this diene the second Diels-Alder reaction of this sequence by generating
vinyl methyl ketone in situ as the dienophile, giving 9a, the structure of which is proven
by X-ray. This facially selective step orients the aroyl group near to the olefin, making it
a good candidate for the final step of the double-tandem sequence, a photochemical
Paternò-Büchi cycloaddition to give 10a.

31

Scheme 2.12: Facial selectivity and Paternò-Büchi reaction

The final photochemical step, which furnishes oxetane 10a, allows for the capture
of a large amount of strain in 10a. With inexpensive starting materials, and high yields
throughout, this sequence exhibits rapid growth in molecular complexity and expeditious
access to a strained scaffold rich in stereocenters. This oxetane was then treated with HCl
to promote protolytic alkene-carbonyl oxametathesis as shown in Scheme 2.1. When a
catalytic amount of H+ was present, the product of this oxametathesis step was an
aldehyde which is easily epimerized and difficult to separate (11a and 11a’). When this
reaction was performed in the presence of excess HCl (> 5 equiv) and excess ethylene
glycol, a single epimer of the acetal (presumably the first epimer formed in the
oxametathesis prior to isomerization) was captured and able to be purified. Surprisingly,
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in addition to the protection of the formyl group, the “cage” ketone distal to the formyl
group was also protected to form the ketal, 12a.
In fact, after the optimization of this process, it was found that the entire
transformation from 10a to 12a could be performed in a one-pot fashion. This one-pot
irradiation reaction was performed on NMR scale in CD2Cl2 by irradiating the sample in
solution along with ethylene glycol and a catalytic amount of HCl, giving 12a as the sole
product.

Scheme 2.13: Products of oxametathesis

Through this study, which was performed in tandem with Roman A. Valiulin (he
was employing chromones rather than 1,4-naphthoquinone as the initial dienophile33), it
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was found that in the presence of excess HCl or BF3- Et2O, a secondary electrophilic
addition of a proton to the styrene takes place, generating a benzylic cation which is
intramolecularly intercepted by the local enol tautomer of the formyl group initially
formed in the oxametathetic step (Scheme 2.14), furnishing the shown product
containing a formylcyclopropane structure (13a). This process is halted by the acetal
protection of the formyl in the presence of ethylene glycol, supporting the proposed
mechanism in which the aldehyde (11a and 11a’) is an intermediate. Additionally, an
epimeric mixture of the aldehyde products treated with an excess of acid, the mixture was
entirely converted into 13a, functionally “purifying” the epimers into a single product.

Scheme 2.14: Mechanism for fomylcyclopropane formation

During the study of this reaction series, there was a fortuitous discovery—
extended irradiation in samples which were not properly degassed resulted in an oxidized
product which contained an oxirane ring. We were able to accelerate and optimize this
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reaction by performing the irradiation after bubbling the samples with O2. The
concentration of oxygen under 1 atm of O2 gas in benzene is 10 mM.35 While the
photoepoxidation of olefins in the presence of organic sensitizers or transition metal
complexes are well known,36 the direct, nonsensitized photoreactions between vinyl
arenes and molecular oxygen are very rare. Only one study was found which proposed a
charge-transfer pair mechanism of such in 1-arylcyclohexenes, and the reported yield was
poor.37
The chromophore for the photoepoxidation reaction is the styrene (the olefin in
13a). While ordinarily this excitation is rapidly dissipated via rotation, these rigid
polycyclic networks prevent such relaxation and improve the efficiency of the epoxide
formation, likely via the interaction with singlet oxygen. In addition to assisting in the
oxirane formation, the rigid and congested scaffold directs the stereochemistry resulting
in complete facial selectivity of the reaction.

Scheme 2.15: Photoepoxidation

These scaffolds are another example of highly unique structures achieved with a
modular approach employing high-yielding conventional and photosynthetic techniques.
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The double-tandem [4+2]◦[2+2]◦[4+2]◦[2+2] sequence employs two photochemical steps
which assist in the construction of the topologically diverse products.

Experimental Procedures and Data
Common solvents were purchased from Pharmco Aaper and used directly, except
for THF—which was refluxed over and distilled from potassium benzophenone ketyl
prior to use—and hexane—which was distilled over calcium hydride. Common reagents
were purchased from Sigma Aldrich, Acros, or TCI America and used without additional
purification, unless indicated otherwise. NMR spectra were recorded at 25 oC on a Bruker
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an
internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker
APEX II instrument. High resolution mass spectra were obtained on the MDS
SCIEX/Applied Biosystems API QSTARTM Pulsar i Hybrid LC/MS/MS System mass
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at
Boulder. For the synthetic details, 1H,
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C, COSY NMR spectra see the supporting

information document in ref 27.

endo-4-(Cyclohex-2-enyl)-1,2-naphthoquinone (7a’): 1.0 g of 1,4naphthoquinone (6.3 mmol) and 0.97 g of 1,3-cyclohexadiene (12.1 mmol) in 20 mL of
1,2-dichlorobenzene at 150 oC (hexane/EtOAc 25:1 f 10:1): 0.75 g (50%). 1H NMR (400
MHz, CDCl3): δ 8.15 (dd, J = 7.6, 1.5 Hz, 1H), 7.69-7.61 (m, 2H), 7.50 (ddd, J = 7.4, 7.4,
36

1.4 Hz, 1H), 6.43 (s, 1H), 6.04 (dddd, J = 9.9, 3.8, 3.8, 2.1 Hz, 1H), 5.60 (dddd, J = 10.1,
3.1, 2.3, 2.3 Hz, 1H), 3.72 (m, 1H), 2.10 (m, 3H), 1.67 (m, 3H).
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C NMR (100 MHz,

CDCl3): δ 181.1, 180.1, 160.6, 135.7, 134.8, 132.0, 131.3, 130.72 overlaps with 130.71,
127.0, 126.6, 126.0, 37.2, 29.0, 25.1, 20.2. HRMS(ESI): calcd for C16H14NaO2+ (MNa+)
261.0886, found 261.0896.

endo-4,5-Benzotricyclo[6.2.1.02,7]undec-9-ene-3,6-dione (7a): A solution
of 5.70 g of 1,4- naphthoquinone (36.0 mmol) and 4.76 mL of freshly distilled 1,3cyclopentadiene (72.2 mmol) was stirred in dichloromethane at ambient temperature for 1
h. Removal of the dichloromethane and excess 1,3-cyclopentadiene by high vacuum gave
7.21 g (99%). 1H NMR (500 MHz, CDCl3): δ 8.00 (m, 2H), 7.67 (m,2H), 5.95 (t, J = 1.8
Hz, 2H), 3.64 (m, 2H), 3.43 (dd, J = 2.5, 1.5Hz, 2H), 1.56-1.49 (m, 2H).

Hexacyclo[5.4.4.0.02,6.03,13.05,14]pentadeca-8,10-diene-12,15-

dione

(8a): A solution of 1.35 g of 7a (6.0 mmol) in 1.0 L of DCM was irradiated in a Pyrex
reaction vessel in a Rayonet reactor equipped with RPR-3500 UV lamps (broadband 300400 nm UV source with a peak emission at 350 nm) for 24 h. Removal of the solvent via
distillation gave 1.30 g (96%). 1H NMR (500 MHz, CDCl3): δ 5.99 (m, 2H), 5.40 (m,2H),
3.36 (m, 2H), 3.01 (m, 2H), 2.82 (m, 2H), 2.01 (d, J = 11.4 Hz,1H), 1.78 (d, J = 11.4 Hz,
1H). 13C NMR (100 MHz, CDCl3): δ 210.5, 124.9, 120.0, 54.8, 51.8, 50.4, 44.4, 39.2.
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1RS, 2SR, 10SR, 11RS, 14RS-14-

.

Benzoylheptacyclo-[9.2.2.12,5.17,10.02,10.04,8.016,17]heptadec-12-ene-3,9-dione (9a): A
solution of 1.30 g of 8a (5.8 mmol) and 0.98 g of 3-chloropropiophenone (5.8 mmol)
was heated in a screw-cap pressure flask at 140oC for 12 h. After the reaction was cooled
to room temperature, the solvent was removed on a high vacuum pump. The crude
reaction mixture was purified on a silica gel flash column using hexane/EtOAc gradient
10:11:1 as the eluent: 1.94 g (94%). 1H NMR(400 MHz, CDCl3): δ 8.07 (d, J = 7.1 Hz,
2H), 7.51 (t, J = 7.3 Hz, 1H), 7.44 (t, J = 7.5 Hz, 2H), 6.45 (ddd, J = 8.2, 6.9, 1.1 Hz,
1H), 6.24 (ddd, J = 8.1, 6.7, 1.3Hz, 1H), 4.10 (ddd, J = 10.0, 5.5, 1.9 1H), 3.06 (ddd, J =
6.6, 1.9, 1.3Hz, 1H), 2.86 (m, 2H), 2.81 (dddd, J = 6.8, 2.8, 2.8, 1.3Hz, 1H), 2.74, (d, J =
2.1 Hz, 2H), 2.62 (m, 2H), 2.26, (ddd, J = 12.8, 10.0, 2.6 Hz, 1H), 1.95 (d, J = 11.2 Hz,
1H), 1.78 (d, J = 11.3 Hz, 1H), 1.71 (ddd, J = 13.0, 5.5, 3.1 Hz, 1H).

13

C NMR (100

MHz, CDCl3): δ 213.4, 212.8, 201.0, 136.2, 134.5, 133.1, 131.2, 129.1, 128.8, 56.3, 56.2,
54.6, 54.4, 43.9, 43.7, 42.2, 42.0, 41.1, 39.8, 34.3,31.2, 23.4. HRMS (ESI): calcd for
C24H21O3+ (MH+) 357.1485, found 357.1479.
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14-Phenyl-13-oxanonacyclo[9.4.2.12,5.17,10.02,10.04,8.012,15.014,17.018,19]
nonadecane-3,9-dione (10a): 0.74 g of 9a (2.1 mmol) was dissolved in 0.5 L of
benzene and irradiated in a Pyrex reaction vessel in a Rayonet reactor equipped with
RPR-3500 UV lamps (broadband 300-400 nm UV source with a peak emission at 350
nm) for 72 h. Removal of the solvent gave via distillation gave 0.68 g (92%). 1H
NMR(500MHz,CDCl3): δ 7.37-7.31 (m, 5H), 4.90 (ddd, J = 3.7, 1.9, 0.8Hz, 1H), 3.46
(dddd, J = 5.5, 3.5, 1.7, 1.7Hz, 1H), 3.03 (dd, J = 8.1, 6.3Hz, 1H), 2.99-2.94 (m, 2H),
2.91 (m, 1H), 2.75 (m, 1H) overlaps with 2.74 (m, 1H), 2.68 (ddd, J = 6.6, 1.8, 1.8Hz,
1H), 2.13 (ddd, J = 7.0, 5.8, 1.3Hz, 1H), 2.04 (d, J = 11.4 Hz, 1H), 1.91 (ddd, J = 13.4,
7.1, 2.0 Hz, 1H) overlaps with 1.87 (d, J = 11.5 Hz, 1H), 1.55 (m, 1H) overlaps with
HOD, 1.44 (dd, J = 13.4, 1.9 Hz, 1H). 1HNMR (500MHz, C6D6): δ 7.32 (m, 2H), 7.157.12 (m, 2H), 7.08 (m, 1H), 4.54 (ddd, J = 3.6, 1.9, 0.9Hz, 1H), 3.14 (m, 1H), 2.74 (d, J =
6.7 Hz, 1H), 2.64 (ddd, J = 6.6, 1.7, 1.7 Hz, 1H), 2.27 (m, 2H), 2.14-2.04 (m, 4H), 1.951.89 (m, 2H), 1.74 (d, J = 11.3 Hz, 1H), 1.19 (d, J = 11.0 Hz, 1H), 1.08 (d, J = 11.0 Hz,
1H).

1SR, 2RS, 5RS, 6RS, 7SR-13,16-Dioxo-4-phenylheptacyclo[5.5.
4.12,5.01,7.08,12.09,15.011,14]heptadec-3-ene-6-carboxaldehyde (11a): To a solution of 100
mg (0.28 mmol) of 4d in 5 mL dichloromethane, 0.09 mL of HCl (4.0 M in dioxane, 0.34
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mmol) was added and stirred for 12 h at ambient temperature. It was then washed with a
5% solution of NaOH (2 x 5 mL), and water (1 x 5 mL). the crude aldehyde was purified
on a silica gel column with hexane/EtOH 10:1 as the eluent. This gave an inseparable
mixture of 11a and 11a’ (2:3). 1H NMR (500 MHz, C6D6): δ 9.17 (s, 1H), 7.20 (d, J = 7.8
Hz, 2H), 7.11 (t, J = 7.4 Hz, 2H), 7.09-7.03 (m, 1H), 5.93 (d, J = 3.1 Hz, 1H), 3.12 (d, J
= 4.1Hz, 1H), 3.09 (dd, J = 5.7, 4.4Hz, 1H), 2.82 (dd, J = 9.1, 5.4 Hz, 1H), 2.69 (dd, J =
5.0, 3.3 Hz, 1H), 2.52-2.49 (m, 2H), 2.33 (ddd, J = 10.3, 4.1, 2.1Hz, 1H), 2.14 (ddd, J =
9.0, 5.8, 1.8Hz, 1H),2.11-2.05 (m, 2H), 1.49 (d, J = 11.1 Hz, 1H), 1.28-1.23 (m, 2H).

1SR,

2RS,

3SR,

6RS,

7SR-13,16-Dioxo-4-phenyloctacyclo[

5.5.4.13,6.01,7.02,4.08,12.09,15.011,14]heptadecane-2-carboxaldehyde (12a): To a solution of
170 mg (0.48 mmol) of 10a in 10 mL dichloromethane, 0.30 mL of BF3-Et2O (48%, 2.38
mmol) was added and allowed to stir at 12 h at ambient temperature. This reaction
mixture was then washed with a 5% solution of NaOH (2 x 5 mL), and water (1 x 5 mL).
the crude aldehyde was purified on a silica gel column with hexane/EtOH gradient
20:1 10:1 as the eluent. 80 mg (47%); OR To a solution of 100 mg (0.28 mmol) of 11a
and 11a’ in 5 mL dichloromethane, 0.14 mL of HCl (4.0 M in dioxane, 0.56 mmol) was
added and allowed to stir for 12 h at ambient temperature . This reaction mixture was
then washed with a 5% solution of NaOH (2 x 5 mL), and water (1 x 5 mL). the crude
mixture was purified on a silica gel column with hexane/EtOH gradient 20:1 10:1 as
the eluent.: 61 mg (61%). 1HNMR(500 MHz,CDCl3): δ 8.85 (s, 1H), 7.31 (d, J = 4.3Hz,
4H), 7.27-7.23 (m, 1H) overlaps with CDCl3, 3.27 (m, 1H) overlaps with 3.26-3.22 (ddd,
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J = 8.2, 5.7, 1.7 Hz, 1H), 3.01 (ddd, J = 7.8, 6.0, 1.6 Hz, 1H), 2.86 (m, 1H) overlaps with
2.86-2.83 (ddd, J = 10.4, 4.0, 1.8Hz, 1H), 2.76-2.73 (ddd, J = 10.3, 4.1, 1.6 Hz, 1H)
overlaps 2.75 (m, 1H), 2.52 (d, J = 13.1 Hz, 1H), 2.22-2.17 (m, 2H), 2.10 (dd, J = 13.1,
5.5 Hz, 1H), 2.06 (d, J = 11.3Hz, 1H), 2.00 (d, J = 12.5Hz, 1H), 1.93 (d, J = 11.3 Hz,
1H).

13

C NMR (100 MHz, CDCl3): δ 212.3, 210.7, 199.3, 138.1, 129.2, 129.0, 127.8,

56.5, 55.4, 54.1, 48.5, 44.9, 44.5, 43.9, 42.6, 41.8, 41.0, 38.9, 38.4, 30.5, 29.8, 28.9.
HRMS(ESI): calcd for C24H21O3+ (MH+) 357.1485, found 357.1477.

13-Ethylene Glycol Monoacetal of 1SR, 2RS, 5RS, 6RS, 7SR-6(1,3-dioxolan-2-yl)-4-phenylheptacyclo[5.5.4.12,5.01,7.08,12.09,15.011,14]

heptadec-3-en-

16-one (13a): To a solution of 360 mg (1.01 mmol) of 10a in an ethylene glycol/THF
mixture (10:3; 10 mL), 1.26 mL of HCl (4.0 M in dioxane, 5.05 mmol) was added. This
reaction mixture was then washed with a 5% solution of NaOH (2 x 5 mL), and water (1
x 5 mL). the crude aldehyde was purified on a silica gel column (treated with 2mL
pyridine) with hexane/EtOH gradient 10:1 5:1 as the eluent.: 229 mg (51%).
1

HNMR(500MHz,CDCl3): δ 7.62 (d, J = 7.2Hz, 2H), 7.30 (t, J = 7.6Hz, 2H), 7.20 (t, J =

7.3Hz, 1H), 6.54 (d, J = 3.6 Hz, 1H), 4.53 (d, J = 9.0 Hz, 1H), 3.96-3.88 (m, 5H), 3.713.62 (m, 2H), 3.53-3.49 (m, 1H), 3.31 (dd, J = 5.6, 4.6Hz, 1H), 2.81 (dd, J = 5.0, 3.6 Hz,
1H), 2.62 (m, 1H), 2.59-2.48 (m, 6H), 2.10 (ddd, J = 10.8, 5.5, 5.5Hz, 1H), 1.80 (d, J =
10.9 Hz, 1H), 1.62 (d, J = 10.5 Hz, 1H), 1.54 (d, J = 10.9 Hz, 1H).
13

CNMR(125MHz,CDCl3): δ 215.8, 147.3, 136.4, 130.7, 128.5, 127.5, 126.2, 114.6,
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104.2, 66.3, 65.5, 64.7, 64.3, 54.3, 51.5, 50.6, 47.5, 44.2, 44.2, 42.7, 40.0, 39.2, 39.0,
38.8, 38.1, 37.1. HRMS (ESI): calcd for C28H28NaO5+ (MNa+) 467.1829, found
467.1822.

13-Ethylene Glycol Monoacetal of 1SR, 2RS, 5RS, 6RS, 7SR-6(1,3-dioxolan-2-yl)-4-phenylheptacyclo[5.5.4.12,5.01,7.08,12.09,15.011,14]heptadec-3-en16-one (13a): from 9a (NMR experiment). To 5 mg (14 μmol) of 3d dissolved in 0.6 mL
of CD2Cl2 in a Pyrex NMR tube were added 4 μL (71 μmol) of ethylene glycol and 17 μL
of 4 M HCl/dioxane. The solution was irradiated with RPR-3500 lamps (λmax=350 nm)
until the starting material was consumed (ca. 3-4 h). At the end of the experiment NMR
of the reaction mixture contained only peaks of 13a, described in the preceding
experiment.

13-Ethylene Glycol Monoacetal of
1S(R),

2S(R),

3S(R),

5S(R),

6R(S),

7S(R)-7-(1,3-Sioxolan-2-yl)-5-phenyl-4-

oxaoctacyclo[6.5.4.12,6.01,8.03,5.09,13.010,16.012,15]octadecane-14,17-dione (14a): 180 mg of 13a (0.40
mmol) dissolved in 100 mL of benzene (4 mM) irradiated for 48 h, solvent was
evaporated, and the crude product was purified by column chromatography on silica gel
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(gradient hexane [0100% EtOAc]): 150 mg (82%). 1H NMR (500 MHz, CDCl3): δ
7.55 (d, J = 6.8 Hz, 2H), 7.40-7.32 (m, 3H), 4.12 (s, 1H), 4.09 (d, J = 9.2 Hz, 1H), 3.993.84 (m, 5H), 3.96-3.88 (m, 5H), 3.62 (ddd, J = 12.0, 6.3, 6.3Hz, 1H), 3.48-3.39 (m, 2H),
3.18 (ddd, J = 9.2, 5.6, 1.6 Hz, 1H), 3.05 (dd, J = 5.3, 5.3 Hz, 1H), 2.76 (m, 1H), 2.66
(ddd, J = 9.0, 4.7, 2.2 Hz, 1H), 2.61-2.51 (m, 5H), 1.89 (d, J = 10.8 Hz, 1H), 1.81 (ddd, J
= 11.2, 5.6, 5.6Hz, 1H), 1.67 (d, J = 10.8Hz, 1H), 1.08 (d, J = 11.2Hz,1H).

13

C NMR

(125MHz, CDCl3): δ 214.1, 136.3, 128.9, 128.6, 114.5, 102.2, 66.21, 66.17, 65.4, 64.4,
63.9, 59.6, 55.0, 53.5, 50.2, 46.8, 44.8, 42.4, 41.7, 40.3, 39.3, 38.9, 36.1, 32.6, 28.2.
HRMS (ESI): calcd for C28H28NaO6+ (MNa+) 483.1778, found 483.1786.
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Chapter 3: Tethered γ- and δ-oxetanes.
Introduction
In the previous chapters, oxetanes were formed and transformed via
oxametathesis from fused polycyclic scaffolds. Our success with the oxetane-cage
adducts led to the consideration of additional Paternò-Büchi competent structures. Prior
studies showed that endo-carbonyl and endo-aroyl photoprecursors in which the bicycle
is directly attached to the carbonyl yield only one type of oxetane, shown in Scheme
3.1.33,38 Also shown is the resulting scaffold from the protolytic oxametathesis reaction.

Scheme 3.1: Oxetane formation, bicyclic structure with endo-carbonyls attached

However, when a scaffold is tethered to a benzoyl chromophore via a methylene
group (see Scheme 3.2), this more flexible linker can allow the resulting oxetane to have
a different regiochemistry, which we have termed γ- and δ-oxetanes, with α- being the
attachment point of the phenacyl pendant to the bicyclic core.
Our aim was to develop a modular design of the photoprecursors and evaluate the
viability of this design as a diversity-oriented synthetic scheme. As such, we explored
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how variations in the diversity inputs changed the photoreactivity of the Paternò-Büchi
step and how these variations manifested in the regio-and stereochemistry of the
subsequent oxametathesis transformation.

Scheme 3.2: Longer tether; two photoproducts

Results and Discussion
The Diels-Alder reaction of cyclohexadiene with methyl propiolate is an efficient
coupling step which gives 1b, a product that is a good target for Michael addition. In this
case, the nucleophile is an aroyl enolate, shown in Scheme 3.3. This furnishes a benzoylcontaining chromophore which can be irradiated to undergo a Paternò-Büchi reaction
with the olefin in the bicyclo[2.2.2] scaffold. Of the diastereomers produced in the
Michael reaction, we were primarily interested in the endo-phenacyl isomers, which were
isolable. This reaction is equally successful when the initial diene is cyclopentadiene, but
the greater steric crowding provided by the 2-carbon bridge from the cycloaddition to
cyclohexadiene provides a greater amount of endo- bias during the Michael addition of
the enolate to the Diels-Alder adduct.
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Scheme 3.3: Michael addition (only endo phenacyl shown)

Acetophenone-derivatives
Scheme 3.4 shows 2b, a bicyclo[2.2.2]octane system resulting from the addition
of acetophenone to 1b in which the methoxycarbonyl is exo-trans to the photoreactive
phenacyl pendant which is situated on the endo-face of the molecule (37%). We propose
that the regiochemistry of the [2+2] photocycloaddition reflects some intrinsic properties
of the system. In this case, upon the irradiation of 2b, oxetanes 3b and 4b form in nearly
1:1 ratio, indicating that with this tether there is no immediately obvious bias for
cyclization. Because of subsequent examples in which hydrogen abstraction reactions are
observed—successfully competing with the Paternò-Büchi channel, it is most likely that
this photochemistry arises from the triplet state of the aroyl pendants.41 Thus, we propose
that this reaction proceeds via intersystem crossing to the triplet state, forming diradical
intermediate, as is typically the case of aroyl chromophores.8,9 The 1,4-diradical isomers
leading to the oxetane products can be classified as exo-trig (e.g. 2b-1) and endo-trig (e.g.
2b-2)40—the exo-trig resulting in the γ products and the endo-trig the δ products.
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Scheme 3.4: 1,4-diradicals in endo- and exo-trig conformations

In general, these oxetanes are not stable on silica gel during purification and only
the δ-oxetane 4b was able to be purified and fully characterized, including via X-ray
crystallographic analysis. In fact, the γ-oxetane was so fragile that during irradiation, it is
only observed by NMR when the irradiation is carried out at 0°C—otherwise, the oxetane
undergoes oxametathesis in situ. Although the γ-oxetane was observed in these low
temperature conditions, it rapidly underwent oxametathesis during any attempts at
purification. Unsurprisingly, the ratio of -oxetane to -oxetane was quite different at 0°C
than at ambient temperature, 1:2 and 1:1 respectively (as measured by 1H NMR
integration). When the sample was irradiated at ambient temperature, we could only
indirectly measure the ratio of -oxetane to -oxetane from the mass balance of the
recovered products after oxametathesis. Figure 3.1 shows the characteristic oxetane
peaks which were observed in the 1H NMR spectrum. The assignment of the -oxetane vs
-oxetane “fingerprint” peaks is supported by predicted spectra calculated at the
B3LYP/6-311+G(d,p) level of theory.
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Figure 3.1: - and - “fingerprint” 1H NMR peaks; 0°C irradiation

Figure 3.2: Calculated  (above) and  (below) oxetane peaks

Also observed during irradiation was an undesired Norrish II side reaction. In this
reaction, the excited chromophore (likely in the triplet state) abstracts the γ-hydrogen
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which is  to the ester group. The resulting 1,4-diradical then fragments into the starting
materials, shown in Scheme 3.5. For the photoprecursor 2b, these Norrish II byproducts
were formed in a 1:2 ratio with the desired oxetanes at ambient temperature.

Scheme 3.5: Norrish type II fragmentation

Scheme 3.6: Oxemetathesis; aldehyde products
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Under the conditions of protolytic oxametathesis (or uncatalyzed fragmentation in
the case of 3b), these - and -oxetanes form the aldehydes (5b’ and 6b’) shown in
Scheme 3.6. Since these aldehydes are easily epimerized in the acidic reaction
conditions, the preferred reaction procedure for the oxametatheis step involved trapping
the aldehydes in cyclic acetals, 1,3-dioxolanes 5b and 6b by performing the
cycloreversion in the presence of ethylene glycol in a one-pot fashion; Scheme 3.7.
These structures were not directly proven with X-ray analysis, but were able to be
assigned by both analogy to proven structures and by careful analysis of the coupling
constants by NMR.

Scheme 3.7: One-pot Paternò-Büchi and oxametathesis

During the one-pot procedure, only a small amount of the -product 5b isolated
with reasonable purity. We found that this was due to a surprising side-reaction which
occurs during the irradiation. We do not at this time propose a formal mechanism, but it
believed to proceed with the assistance of dissolved O2. Three separate products formed
which were oxidized in the allylic position.
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Scheme 3.8: Allylic oxidation products of 5b

The addition of singlet oxygen (generated in photochemical conditions with the
assistance of a sensitizer such as acenaphthenequinone or tetraphenylporphine) to an
olefin via an ene-type mechanism is precedented.14,41 While product in the examples
referenced are all peroxides, it is conceivable that in our examples, singlet oxygen added
in a similar fashion, but decomposed to give the alcohol rather than the peroxide (see
Scheme 1.8). While these reaction conditions did not contain a sensitizer to assist the
generation of singlet oxygen, many reaction schemes employ aroyl compounds as
sensitizers—and it happens that our initial chromophore for the Paternò-Büchi reaction is
indeed an aroyl species and could be acting as a sensitizer.
In all, this tethered system derived from acetophenone provides the
conformational flexibility necessary for the formation of both -and -oxetanes whose
photoprotolytic transformation provides rapid access to diverse polycycles decorated with
a variety of rigidly held functional groups.
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Propiophenone Derivatives
When the enolate of propiophenone is used in the Michael addition, several
diastereomers are formed, and only those which possess an endo-aroyl group should be
Paternò-Büchi competent. We were able to isolate several of the isomers, with the transdiastereomer possessing endo-phenacyl and exo-methoxycarbonyl groups being the major
product (10b).

Scheme 3.9: endo-phenacyl isomers of propiophenone addition

When subjected to Paternò-Büchi conditions followed by oxametathesis, 10b
showed high regioselectivity. The irradiation reaction exclusively produced the δ –
oxetane 14b (>95% by 1H NMR) which was able to be purified and isolated in 65%
yield—the reduction in yield is due to the precedented fragility of oxetanes on silica gel.
Since the length of the tether in 10b is identical 2b, the initial conformational bias is
likely due to the lower energy ground state conformation in which the benzoyl and
methyl group are “out” (i.e., the hydrogen is “in,” see Newman projection in Scheme
3.10). Thus we posit that the formation of the oxetane proceeds with the least motion of
the excited chromophore relative to the olefin in the bicyclic core, when the lowest
energy ground state conformation is considered (i.e., the hydrogen is under the bicyclic
framework).
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Scheme 3.10: “Least motion” cyclization

The protolytic ring opening of 14b required that the temperature be elevated to
70°C due to an elimination reaction at ambient temperature. The structure of 16b was
unambiguously proven via X-ray crystallographic analysis. The structure of 15b was
determined via careful analysis of NMR constants, mechanistic interpretation, and
analogy to the acetophenone-derived analog, 6b. As expected, only the fused ring product
is formed from 14b.

Scheme 3.11: Oxametathesis and elimination products

The “least motion” hypothesis for the formation of solely the -oxetane from 10b
is supported by an NMR experiment. The first example is the irradiation of 11b, which is
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diasteromeric to 10b with respect to the position of the methyl group. Additionally, a
sample of 12b was irradiated, which has the same tether stereochemistry (i.e., “methylin”) as 11b but has the ester cis- to the endo-aroyl group. The irradiation of these adducts
resulted in the -oxetane in both cases. 12b to 18b was able to be observed directly and
the spectrum contained the characteristic “gamma” peak (referenced in Figure 3.1).
Similarly, 11b was irradiated (albeit, in a mixture with another compound), and the
gamma product was observed in the mixture (17b). Thus it is our hypothesis that the
lowest energy configuration of the starting material introduces sufficient steric constraint
to control which oxetane is formed.

Scheme 3.12: Isomers which form -oxetanes

Calculations**
In the aforementioned acetophenone system in which the δ - and γ-oxetanes are
produced in 1:1 ratio (at ambient temperature), calculations showed that the δ-oxetane 4b
is approximately 11 kcal/mol more stable than the γ-oxetane 3b (B3LYP/6-311+G(d,p),
Gaussian 09, A.02). When the stability of the diradicals 2b-1 and 2b-2 is considered, the
γ-diradical is 6.6 kcal/mol more stable than the δ-diradical. Their 1:1 ratio implies that
while the γ-diradical may be forming to a greater extent, it less often closes into the 4-

**

See SI from [42] for full reference and computational details; Calculations were run by Dr. Andrei
Kutateladze.
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membered ring due to thegreater strain associated with the γ-oxetane. Because of the
unfavorable energetics for the formation of the γ-oxetane, we propose that the γdiradicals partition into the back reaction to form the starting material more frequently
than do the δ-diradicals, which more readily collapse into the oxetane. Because of this
partitioning of the γ-diradicals, the two trends of the more stable γ-diradical vs. the more
stable -oxetane cancel each other out. This is perhaps why a 1:1 ratio is observed. The
0oC experiment in which there was a 1:2 ratio of -oxetane to supports this hypothesis. At
lower temperature, it follows that the kinetically favored γ-oxetane would form more
frequently than the thermodynamically favored -oxetane.

Figure 3.3: NMR spectra; (bottom) 12b in C6D6, no irradiation; (top) irradiated 10 min,
18b
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However, when the methyl group is introduced on the tether via the addition of
propiophenone in 10b, the diastereomeric changes introduced into the tether alter the
stability of the radical intermediates. The calculations show that the energy difference for
the δ- vs γ-diradicals formed from 10 is only 2.8 kcal/mole in favor of the γ-diradical
10b-1 (δ-diradical is 10b-2), but the δ-oxetane is still ~11 kcal/mole more stable than the
γ-oxetane (calculations not shown on table). With the smaller energy gap in the stability
of the diradicals, the bias is not likely due to the divergent population of the - vs intermediates. We must then assume that the methyl group reduces rotational freedom of
the tethered endo-phenacyl group, and it is this rotational constraint that gives bias to the
productive formation of 14b and the likely decay of the -diradical back to the ground
state without the formation of a product.

Scheme 3.13: Least motion hypothesis; -diradical does not give the oxetane

In addition, for the photochemical reaction of 11b and 12b, which formed
exclusively the -oxetanes, the - vs- -diradical stability changes yet again, with -being
more stable in both cases; 7.8 kcal/mol and 7.3 kcal/mol respectively. The -oxetane is
again the thermodynamically favored product in both cases, but the rotational barrier due
to the methyl group combined with the slightly increased energy penalty of the 56

diradical seems to create enough system bias that -oxetanes 17b and 18b are the only
products of irradiation.

3b

4b

10b-2
2b-1

2b-2
10b-1

Table 3.1: B3LYP/6-311+G(d,p), Gaussian 09, evision A.02, from [33]

This modular reaction scheme gave a great deal of insight into how perturbations
in the tether of these endo-phenacyl compounds alters the regiochemistry of the products
in the photochemical step. Additionally, this is another example in which the simple,
inexpensive starting materials are transformed into much more highly complex
polyheterocyclic scaffolds which have a variety of functional groups rigidly held about
the framework. While the introduction of the methyl group in the tether complicated the
isolation yield of the photoprecursors, the tether itself allowed the system to demonstrate
complete regioselectivity in the product.
57

Experimental Procedures and Data
Common solvents were purchased from Pharmco Aaper and used directly, except
for THF—which was refluxed over and distilled from potassium benzophenone ketyl
prior to use—and hexane—which was distilled over calcium hydride. Common reagents
were purchased from Sigma Aldrich, Acros, or TCI America and used without additional
purification, unless indicated otherwise. NMR spectra were recorded at 25 oC on a Bruker
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an
internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker
APEX II instrument. High resolution mass spectra were obtained on the MDS
SCIEX/Applied Biosystems API QSTARTM Pulsar i Hybrid LC/MS/MS System mass
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at
Boulder. For the 1H,

13

C, COSY NMR spectra which are not included in Appendix A,

see supporting information from ref. [42].

Methyl bicyclo[2.2.2]octa-2,5-diene-2-carboxylate (1b): A solution of
propiolic acid methyl ester (3.0 mL of propiolic acid methyl ester, 33.6 mmol) and 1,3cyclohexadiene (7.5 mL of 1,3-cyclohexadiene 78.7 mmol) in 10 mL of 1,2dichlorobenzene was heated in a screw-cap pressure vessel at 70−75°C overnight. After
the reaction was cooled to room temperature, the solvent was removed on a high vacuum
pump. The crude reaction mixture was purified on a silica gel column using a mixture of
hexane and EtOAc as an eluent.: 5.17 g (88%). 1H NMR (500 MHz, CDCl3) δ = 7.29 (dd,
J = 6.4, 1.9 Hz, 1H), 6.38 (ddd, J = 7.4, 6.1, 1.5 Hz, 1H), 6.27 (ddd, J = 7.3, 5.9, 1.5 Hz,
1H), 4.20 (m, 1H), 3.76 (m, 1H), 3.73 (s, 3H), 1.38−1.29 (m, 4H).
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Michael Addition
General Procedure: Fresh LDA (1.8 M solution, 1.3 equiv) was added under nitrogen
atmosphere to the solution of an aroyl compound (1.0 equiv; acetophenone or
propiophenone) in THF at 0 °C. After the anion was generated (in 20−30 min), the
Diels−Alder adduct (1−6) was added (1.0 equiv) and the solution was allowed to warm to
ambient temperature. The resulting mixture was stirred for 10−20 h. After the reaction
was completed DCM was added, and the resulting mixture was quenched with NH4Cl
and washed with water and brine. The organic layer was dried over anhydrous Na2SO4
and removed under a vacuum. The crude mixture was purified on a silica gel column
using a mixture of hexane and EtOAc as an eluent. In some cases, LDA was prepared via
diisopropylamine (1.4 eq) dissolved in THF at -10oC, then n-BuLi was added (1.6 M
solution in hexanes, 1.2 eq) and stirred for 20 min, then the aroyl compound was added to
this mixture). The same procedure outlined above was followed after this point.

Methyl

endo-5-phenacylbicyclo[2.2.2]oct-2-ene-exo-6-carboxylate

(2b): From 10.7 mL of LDA (1.8 M solution, 19.18 mmol), 1.75 mL of acetophenone
(15.06 mmol) and 2.25 g of 1b (13.70 mmol) (hexane/EtOAc gradient 50:1 → 10:1): 1.40
g (37%). 1H NMR (500 MHz, CDCl3) δ = 7.95 (d, J = 8.1 Hz, 2H), 7.57 (t, J = 7.4 Hz,
1H), 7.47 (t, J = 7.8 Hz, 2H), 6.40 (ddd, J = 8.0, 6.8, 1.1 Hz, 1H), 6.25 (t, J = 7.1 Hz,
1H), 3.74 (s, 3H), 2.91 (dd, J = 16.3, 7.6 Hz, 1H), 2.86−2.80 (m, 2H), 2.77 (dddd, J =
12.7, 5.4, 1.8, 1.8 Hz, 1H), 2.54 (m, 1H), 2.07 (dt, J = 5.4, 2.3 Hz, 1H), 1.73−1.62 (m,
2H), 1.34−1.27 (m, 1H), 1.17−1.10 (m, 1H).
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13

C NMR (500 MHz, CDCl3) δ = 198.4,

175.0, 137.0, 134.3, 133.0, 132.9, 128.5, 128.1, 51.8, 50.1, 46.0, 36.8, 34.3, 33.0, 25.2,
20.1. HRMS (ESI/TOF) calcd for C18H20NaO3+ (MNa+) 307.1310, found 307.1292.

Methyl (2RS, 4SR, 5SR, 6RS, 9SR)-endo-5-(1-methylphenacyl)bicyclo
[2.2.2]oct-2-ene-exo-6-carboxylate (10b). from 0.53 mL of diisopropylamine (3.78
mmol), 2.0 mL of n-BuLi (3.24 mmol) , 0.40 mL of propiophenone (3.01 mmol) and 0.49
g of 2b (3.01 mmol). (hexane/ EtOAc gradient 30:1 → 10:1): 0.24 g (29%). 1H NMR
(500 MHz, CDCl3) δ = 7.92 (d, J = 7.6 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 7.8
Hz, 2H), 6.34 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H), 6.24 (t, J = 7.3 Hz, 1H), 3.73 (s, 3H), 3.26
(dt, J = 15.3, 7.1 Hz, 1H), 2.75−2.71 (m, 1H), 2.71−2.67 (m, 1H), 2.61 (ddd, J = 8.3, 5.7,
1.7 Hz, 1H), 2.01−1.99 (m, 1H), 1.67−1.61 (m, 2H), 1.35−1.27 (m, 1H), 1.17 (d J = 7.0
Hz, 3H), 1.14−1.06 (m, 1H).

13

C NMR (500 MHz, CDCl3) δ = 204.0, 175.1, 137.0,

133.75, 133.0, 132.8, 128.6, 128.3, 51.7, 49.4, 46.1, 43.2, 33.4, 31.3, 25.3, 20.5, 15.8.
HRMS (ESI/TOF) calcd for C19H23NaO3+ (MNa+) 299.1642, found 299.1649.

Methyl

(2RS,

4SR,

5SR,

6RS,

9RS)-endo-5-(1-

methylphenacyl)bicyclo[2.2.2] oct-2-ene-exo-6-carboxylate (11b): From 0.53 mL of
diisopropylamine (3.78 mmol), 2.0 mL of n-BuLi (3.24 mmol), 0.40 mL of
propiophenone (3.01 mmol) and 0.49 g of 2b (3.01 mmol) (hexane/ EtOAc gradient 30:1
→ 10:1): 0.12 g (10%). (NMR extracted from a mixture). 1H NMR (500 MHz, CDCl3) δ
= 7.96 (d, J = 8.3 Hz, 2H), 7.59 (t, J = 7.8 Hz, 1H), 7.49 (t, J = 7.9 Hz, 2H), 6.28 (d, J =
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7.6Hz, 1H), 6.08 (t, J = 7.2 Hz, 1H), 3.74 (s, 3H), 3.14 (dddd, J = 10.3, 7.0, 7.0, 7.0, 1H),
2.87 (m, 1H), 2.81-2.75 (m, 1H), 2.72-2.67 (m, 1H), 2.35 (m, 1H), 2.17 (ddd, J = 5.7, 2.6,
2.0 Hz, 1H), 1.67-1.57 (m, 4H).

Methyl (2RS, 4SR, 5SR, 6SR, 9RS)-endo-5-(1-methylphenacyl)bicyclo
[2.2.2]oct-2-ene-endo-6-carboxylate (12b) From 0.53 mL of diisopropylamine (3.78
mmol), 2.0 mL of n-BuLi (3.24 mmol), 0.40 mL of propiophenone (3.01 mmol) and 0.49
g of 2b (3.01 mmol) (hexane/ EtOAc gradient 30:1 → 10:1): 0.07 g (6%). 1H NMR (500
MHz, CDCl3) δ = 8.03 (d, J = 7.8 Hz, 2H), 7.61 (t, J = 7.6 Hz, 1H), 7.51 (t, J = 7.8 Hz,
2H), 6.28 (t, J = 7.4 Hz, 1H), 6.06 (t, J = 7.8 Hz, 1H), 3.87 (ddd, J = 17.5, 6.7, 6.7 Hz,
1H), 3.69 (s, 3H), 3.02 (dd, J = 9.9, 1.9 Hz, 1H), 2.76 (m, 1H), 2.46 (ddd, J = 11.1, 9.8,
1.7 Hz, 1H), 2.36 (m, 1H), 1.34-1.10 (m, 4H). 1H NMR (500 MHz, C6D6) δ = 8.14 (d, J
= 7.8 Hz, 2H), 7.10 (t, J = 7.4 Hz, 1H), 7.05 (t, J = 7.8 Hz, 2H), 6.26 (t, J = 7.4 Hz, 1H),
6.00 (t, J = 7.6 Hz, 1H), 4.12 (ddd, J = 17.6, 6.6, 6.6 Hz, 1H), 3.31 (s, 3H), 2.83 (dd, J =
9.8, 1.9 Hz, 1H), 2.54-2.44 (m, 3H), 1.31 (m, 1H), 1.19 (m, 1H), 1.01 (m, 1H), 0.95 (m,
1H).

Methyl

(2RS,

4SR,

5SR,

6SR,

9SR)-endo-5-(1-

methylphenacyl)bicyclo [2.2.2]oct-2-ene-endo-6-carboxylate (13b): From 0.53 mL of
diisopropylamine (3.78 mmol), 2.0 mL of n-BuLi (3.24 mmol), 0.40 mL of
propiophenone (3.01 mmol) and 0.49 g of 2b (3.01 mmol) (hexane/ EtOAc gradient 30:1
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→ 10:1): 0.11 g (10%). (NMR extracted from a mixture). 1H NMR (500 MHz, CDCl3) δ
= 7.93 (d, J = 8.7 Hz, 2H), 7.53 (t, J = 8.2 Hz, 1H), 7.45 (t, J = 8.5 Hz, 2H), 6.42-6.35 (m,
2H), 3.61 (ddd, J = 17.4, 7.4, 7.4, 1H), 3.01 (s, 3H), 2.81-2.74 (m, 2H), 2.70 (m, 1H),
1.68-1.59 (m, 3H), 1.39 (ddd, J = 12.3, 9.0, 3.7, 1H), 1.33-1.27 (m, 1H).

Methyl (1RS, 3SR, 4RS, 5RS,
6SR, 9RS, 10SR)-11-oxa-3-phenyltetracyclo[4.3.1.13,5.04,9]undecane-10-carboxylate
(4b). A solution of 0.18 g of 2b (0.63 mmol) in 120 mL benzene was irradiated for 20 h
in a Pyrex reaction vessel in a Rayonet reactor equipped with RPR-3500 UV lamps
(broadband 300-400 nm UV source with peak emission at 350 nm). The crude reaction
mixture was purified on a silica gel column using hexane/EtOAc gradient 30:1 → 5:1 as
the eluent: 79 mg (44%). 1H NMR (500 MHz, CDCl3) δ = 7.40−7.36 (m, 3H), 2H in
aromatic region obscured by CDCl3, 4.67 (dd, J = 8.0, 5.1 Hz, 1H), 3.78 (s, 3H), 3.33 (d,
J = 4.5 Hz, 1H), 3.12 (dd, J = 6.4, 5.1 Hz, 1H), 3.05−3.01 (m, 1H), 2.52 (q, J = 9.4, 4.7
Hz, 1H), 2.22−2.18 (m, 1H), 2.16−2.02 (m, 1H), 1.91−1.83 (m, 1H), 1.65−1.58 (m, 1H),
1.56−1.50 (m, 1H), 1.14−1.06 (m, 1H).

13

C NMR (500 MHz, CDCl3) δ = 176.6, 142.4,

128.2, 126.9, 124.0, 96.0, 51.7, 47.4, 44.1, 44.1, 36.2, 32.6, 17.2, 17.0. HRMS (ESI/TOF)
calcd for C18H20NaO3+ (MNa+) 307.1310, found 307.1317. See [42] for X-ray data.
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Methyl (1SR, 2SR, 3SR, 4RS, 5RS, 6SR, 9RS, 10SR)-1-methyl-11oxa-3phenyltetracyclo[4.3.1.13,5.04,9]undecane-10-carboxylate (14b). A solution of 0.55 g of
10b (018 mmol) in 120 mL benzene was irradiated for 20 h in a Pyrex reaction vessel in
a Rayonet reactor equipped with RPR-3500 UV lamps (broadband 300-400 nm UV
source with peak emission at 350 nm). The crude reaction mixture was purified on a
silica gel column using hexane/EtOAc gradient 30:1 → 5:1 as the eluent: 36 mg
(65%).1H NMR (500 MHz, CDCl3) δ = 7.38 (t, J = 7.6 Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H),
7.27 (t, J = 7.2 Hz, 1H), 4.66 (dd, J = 7.9, 5.1 Hz, 1H), 3.78 (s, 3H), 3.42 (d, J = 4.7 Hz,
1H), 3.07 (ddd, J = 7.8, 4.9, 1.3 Hz, 1H), 2.85 (t, J = 5.1 Hz, 1H), 2.50 (q, J = 9.4, 4.7 Hz,
1H), 2.27−2.18 (m, 2H), 1.91−1.82 (m, 1H), 1.67−1.60 (m, 1H), 1.54−1.47 (m, 1H),
1.13−1.05 (m, 1H), 0.92, (d, J = 6.9 Hz, 3H).

13

C NMR (500 MHz, CDCl3) δ = 176.9,

143.9, 128.0, 126.6, 126.0, 124.0, 96.1, 51.7, 48.1, 47.8, 42.8, 37.6, 35.1, 32.5, 14.7, 17.1,
6.4. HRMS (ESI/TOF) calcd for C19H22NaO3+ (MNa+) 321.1467, found 321.1450.

Methyl (1SR, 2RS, 3RS, 5SR, 6SR, 7SR, 10RS, 11SR)-2-methyl-4oxa-3-phenyltetracyclo[5.3.1.02.5.03,8]undecane-10-carboxylate (18b): 5 mg of 12b
was dissolved in C6D6 in an NMR tube and then irradiated in a Rayonet reactor equipped
with RPR-3500 UV lamps (broadband 300-400 nm UV source with a peak emission at
350 nm); 100% conversion.

1

H NMR (500 MHz, C6D6) δ = 7.78 (d, J = 7.4 Hz, 2H),
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7.28 (t, J = 7.7 Hz, 2H), 7.08 (t, J = 7.4 Hz, 1H), 4.02 (ddd, J = 6.9, 1.6, 1.6 1H), 3.32 (s,
3H), 3.09, (t, J = 6.6 Hz, 1H), 2.43 (d, J = 6.2 Hz, 1H), 2.33 (m, 1H), 2.25 (t, J = 6.2 Hz,
1H), 2.07 (m, 1H), 1.95 (q, J = 13.5, 6.7 Hz, 1H), 1.03-0.95 (m, 4H).

Methyl endo-3-(1,3-dioxalan-2-yl)-8-phenylbicyclo[4.3.0]non7-ene-exo-2-carboxylate (6b). A solution of 0.18 g of 7a (0.63 mmol), 0.22 mL of HCl
solution (4 M in dioxane, 0.89 mmol) and 0.08 g ethylene glycol (1.26 mmol) was
prepared in dichloromethane (130 mL) in a Pyrex reaction vessel. This solution was
irradiated for 29 h. The crude reaction mixture was purified on a silica gel column using a
mixture of hexane and EtOAc as an eluent. The reaction mixture was then concentrated
in vacuo to a volume of 20 mL and washed with saturated sodium bicarbonate solution (2
× 15 mL), and the aqueous layer was extracted with dichoromethane (2 × 20 mL). The
combined organic layers were dried over anhydrous sodium sulfate, and the solvent was
removed in vacuo to give a crude yellow oil. The crude mixture was purified on a silica
gel column using hexane and ethyl acetate as the eluent (hexane/EtOAc gradient 30:1 →
5:1), 63 mg (30%). 1H NMR (500 MHz, CDCl3) δ = 7.44 (d, J = 7.9 Hz, 2H), 7.34 (t, J =
7.4 Hz, 2H), 7.25 (t, J = 7.4 Hz, 1H), 6.01 (t, J = 2.2 Hz, 1H), 4.71 (d, J = 3.9 Hz, 1H),
3.94−3.77 (m, 4H), 3.72 (s, 1H), 3.11 (s, 1H), 2.80 (dddd, J = 15.4, 6.2, 3.7, 2.6 Hz, 1H),
2.59 (dt, J = 12.8, 6.5 Hz, 1H), 2.53 (d, J = 15.4 Hz, 1H), 2.32 (t, J = 11.2 Hz, 1H),
2.05−2.96 (m, 2H), 1.77−1.67 (m, 2H), 1.35−1.24 (m, 2H). 13C NMR (500 MHz, CDCl3)
δ = 176.9, 142.0, 136.6, 129.6, 128.3, 127.1, 125.5, 106.1, 65.0, 64.9, 51.5, 45.2, 45.0,
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41.2, 41.1, 38.9, 26.1, 22.0. HRMS (ESI/TOF) calcd for C20H24LiO4+ (MLi+) 335.1835,
found 335.1829.

Methyl 6-(1,3-dioxalan-2-yl)-3-phenylbicyclo[3.3.1]non-2-ene-syn9-carboxylate (5b). A solution of 0.18 g of 2b (0.63 mmol), 0.22 mL of HCl solution (4
M in dioxane, 0.89 mmol) and 0.08 g ethylene glycol (1.26 mmol) was prepared in
dichloromethane (130 mL) in a Pyrex reaction vessel. This solution was irradiated for 29
h. The crude reaction mixture was purified on a silica gel column using a mixture of
hexane and EtOAc as an eluent. The reaction mixture was then concentrated in vacuo to a
volume of 20 mL and washed with saturated sodium bicarbonate solution (2 × 15 mL),
and the aqueous layer was extracted with dichoromethane (2 × 20 mL). The combined
organic layers were dried over anhydrous sodium sulfate, and the solvent was removed in
vacuo to give a crude yellow oil. The crude mixture was purified on a silica gel column
using hexane and ethyl acetate as the eluent (hexane/EtOAc gradient 30:1 → 5:1),
epimeric mixture, 38 mg (18%). HRMS (ESI/TOF) calcd for C20H24NaO4+ (MNa+)
351.1572, found 351.1558.

(1RS,4RS, 5SR, 8RS, 9SR)-Methyl 8-(1,3-dioxalan-2-yl)-4hydroxy-3-phenylbicyclo[3.3.1]non-2-ene--9-carboxylate (7b): See procedure for 5b:
12 mg (5%). 1H NMR (500 MHz, CDCl3) δ = 7.54 (d, J = 7.6 Hz, 2H), 7.40 (t, J = 7.5
Hz, 2H), 7.33 (t, J = 7.0 Hz, 1H), 6.26 (d, J = 6.6 Hz, 1H), 4.63m (dd, J = 3.7, 1.2 Hz,
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1H), 4.55 (d, J = 6.7 Hz, 1H), 4.02-3.93 (m, 2H), 3.88-3.81 (m, 2H), 3.78 (s, 3H), 3.22
(dt, J = 6.0, 2.8 Hz, 1H), 3.00 (s, 1H), 2.63 (s, 1H), 1.94-1.87 (m, 1H), 1.87-1.79 (m,
1H), 1.95-1.71 (m, 2H), 1.56-1.49 (m, 1H).

13

C NMR (500 MHz, CDCl3) δ = 173.8,

141.9, 138.8, 128.8, 127.8, 126.4, 1106.1, 71.6, 64.9, 64.7, 51.7, 40.6, 30.9, 37.2, 33.3,
24.9, 19.2.

(1RS,2RS, 5SR, 6RS, 9SR)-2-(2-hydroxyethyl-9-methyl-6-exohydroxy-7-phenylbicyclo[3.3.11]non-7-ene-2,9-dicarboxylate (8b): See procedure for
5b: 8 mg (3%). 1H NMR (500 MHz, CDCl3) δ = 7.50 (d, J = 8.1 Hz, 2H), 7.37 (t, J = 7.5
Hz, 2H), 7.30 (t, J = 7.5 Hz, 1H), 6.22 (d, J = 6.5 Hz, 1H), 4.61 (dd, J = 3.4, 1.2 Hz, 1H),
4.25-4.14 (m, 2H), 3.81 (q, J = 9.9, 4.9, 2H), 3.78 (s, 3H), 3.39 (dt, J = 9.5, 3.1 Hz, 1H),
3.05 (t, J = 2.8 Hz, 1H), 2.85 (dt, J = 12.8, 3.5 Hz, 1H), 2.62 (s, 1H), 1.87 (t, J = 5.9 Hz),
1.77-1.69 (m, 4H).

13

C NMR (500 MHz, CDCl3) δ = 174.2, 173.8, 142.8, 138.5, 128.8,

128.0, 127.6, 126.4, 71.3, 66.1, 51.9, 40.4, 36.9, 33.8, 25.1, 20.2.

2-exo-Hydroxy-3-phenyl-11-oxatricyclo[4.3.2.05,9]dodec-3-ene-10one (9b): See procedure for 5b:, 5 mg (2%).1H NMR (500 MHz, CDCl3) δ = 7.55 (d, J =
8.0 Hz, 2H), 7.44-7.32 (m, 3H), 6.16 (d, J = 5.7 Hz, 1H), 4.81 (t, J = 5.0 Hz, 1H), 4.55 (q,
J = 4.6, 2.4 Hz, 1H), 3.26 (dt, J = 11.9, 6.0, 1H), 2.95 (t, J = 4.7 Hz, 1H), 2.54 (m, 1H),
2.11-1.98 (m, 1H), 1.82 (d, J = 4.6, 1H)
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Methyl

endo-3-(1,3-dioxalan-2-yl)-endo-10-methyl-8-

phenylbicyclo [4.3.0]non-7-ene-exo-2-carboxylate (15b). A solution of 0.21 g of 14b
(0.70 mmol), 0.25 mL of HCl solution (4 M in dioxane, 0.99 mmol) and 0.09 g ethylene
glycol (1.40 mmol) was prepared in chloroform (10 mL) and then heated to 70 °C while
stirring for 4 h. The reaction mixture was then concentrated in vacuo to remove
chloroform, diluted with dichoromethane (10 mL), and washed with saturated sodium
bicarbonate solution (2 × 15 mL), and the aqueous layer extracted with dichoromethane
(2 × 10 mL). The combined organic layers were dried over anhydrous sodium sulfate, and
the solvent removed in vacuo to give a crude yellow oil. The crude mixture was purified
on a silica gel column using hexane and ethyl acetate as the eluent (hexane/EtOAc
gradient 30:1 → 5:1), 0.17 g (71%). 1H NMR (500 MHz, CDCl3) δ = 7.35−7.31 (m, 4H),
7.25 (t, J = 7.2 Hz, 1H), 5.87 (t, J = 2.1 Hz, 1H), 4.79 (d, J = 3.7 Hz, 1H), 4.01−3.85 (m,
3H), 3.71 (s, 3H), 3.31 (tt, J = 7.7, 1.7 Hz, 1H), 2.95− 2.82 (m, 2H), 2.68 (t, J = 11.5 Hz,
1H), 2.08−2.00 (m, 2H), 1.78− 1.71 (m, 2H), 1.56−1.48 (m, 2H), 1.08 (d, J = 7.4 Hz,
3H).

Methyl

endo-5-hydroxy-2-methyl-3-

phenyl tricyclo[4.3.1.04,9]dec-2-ene-exo-10-carboxylate (16b). A solution of 0.11 g of
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14b (0.37 mmol) and 0.13 mL of HCl solution (4 M in dioxane, 0.51 mmol) was prepared
in chloroform (10 mL) and stirred at ambient temperature for 4 h. The reaction mixture
was then concentrated in vacuo to remove chloroform, diluted with dichoromethane (10
mL), and washed with saturated sodium bicarbonate solution (2 × 15 mL), and the
aqueous layer extracted with dichoromethane (2 × 10 mL). The combined organic layers
were dried over anhydrous sodium sulfate, and the solvent removed in vacuo to give a
crude yellow oil. The crude mixture was purified on a silica gel column using hexane and
ethyl acetate as the eluent (hexane/EtOAc gradient 30:1 → 5:1), 80 mg (73%). The
structure is characterized by X-ray (see Supporting Information). 1H NMR (500 MHz,
CDCl3) δ = 7.45 (d, J = 8.4 Hz, 2H), 7.37 (t, J = 7.7 Hz, 2H), 7.24 (t, J = 7.4 Hz, 1H),
4.03 (dt, J = 8.5, 2.2 Hz, 1H), 3.75 (s, 3H), 3.15 (dd, J = 8.7, 4.3 Hz, 1H), 2.88 (d, J = 4.5
Hz, 1H), 2.76−2.74 (m, 1H), 2.54−2.50 (m, 1H), 2.32−2.28 (m, 1H), 2.03 (s, 3H),
1.80−1.59 (m, 4H) .

13

C NMR (500 MHz, CDCl3) = 175.9, 145.5, 137.7, 137.3, 128.2,

128.1, 126.5, 69.3, 51.8, 51.4, 48.2, 42.3, 38.3, 38.1, 21.9, 18.1, 14.6. HRMS (ESI/TOF)
calcd for C19H22LiO3+ (MLi+) 305.1728, found 305.1729.
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Chapter 4: Azaxylylenes
Introduction
In a departure from oxetanes, let us consider other photochemically assisted
syntheses which employ modular design toward novel polyheterocycles, and in some
cases further reactions of the photoproducts. o-Azaxylylenes have been known for half a
century43 but have remained in relative synthetic obscurity until a decade ago. Corey
reported their first preparation under simple mild conditions via base-induced elimination
of hydrogen chloride from derivatives of o-chloromethylaniline, noting that
“Surprisingly, simplest method possible for o-azaxylylene production [...] has never been
reported.”44

Scheme 4.1: Parent structures of Corey’s azaxylylene formation44

Since the synthetic utility of o-xylylenes (i.e. all-carbon o-quinodimethanes) is
well-reported,45 and the photophysics of their generation via intramolecular photoinduced
hydrogen abstraction in aromatic o-alkyl ketones is also studied,46 it was surprising for us
to realize that the equally simple photogeneration of o-azaxylylenes from oaminoketones via excited state intramolecular proton transfer47 has never been utilized as
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a synthetic tool. Indeed, such utilization may have been attempted but was unsuccessful
due to the rapid reversibility of the initial proton transfer which could compete with a
desired reaction (in our case, cycloaddition). Intramolecular proton transfers from one
heteroatom to another (and back) are fast: a classic example is the much studied
photophysics of salicylaldehyde or o-hydroxyacetophenone, although the transient
tautomer is not impossible to characterize.48 We, however, found that the cycloaddition
reactions of o-azaxylylenes photogenerated via excited state intramolecular proton
transfer (ESIPT) can successfully compete with the back proton transfer when an
unsaturated dienophile is tethered to the photoprecursor, resulting in an intramolecular
cycloaddition.49 Additionally, this modular system allowed for the unique photochemical
participation of imines and thiophenes—likely achievable due to the tethered pendant
design. Shown in Scheme 4.2 is a sample reaction scheme in which an azaxylylene is
generated by the proton abstraction by a carbonyl from an amide which bears a thiophene
pendant.

Scheme 4.2: Cycloaddition to azaxylylenes

Carbonyl-type Azaxylylenes
Results and Discussion
Thiophene propionic acid choride (3c) was successfully coupled to TMSprotected o-aminobenzyl alcohol (1c), o-aminoacetophenone, and o-aminotetralone (2c);
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Scheme 4.3. In the case of the o-aminobenzyl alcohol, the product was deprotected and
subsequently oxidized to give the aldehyde (the ketones were able to be used directly). A
similar photoprecursor was synthesized in which thiophene was tethered to oaminoinadanone, but it was not photochemically reactive. Olga A, Mukhina found that
this indanone derivative was indeed able to undergo the desired cycloaddition, albeit
slowly, when the tethered pendant was furan—which is far more reactive than thiophene.
When indanone was tethered to thiophene, the prohibitively slow reaction time resulted
in the degradation of the starting material rather than in the formation of the desired
cycloaddition product.

Scheme 4.3: Synthesis of photoprecursors

These o-acylamido precursors have broad UV absorption with a maximum at 340350 nm. Irradiations were carried out with a Rayonet broadband 300-400 nm UV source
(which has a maximum emission at 350 nm). The thiophenes were able to undergo
diastereoselective [4+2] cycloaddition to give dihydrothiophenes (Scheme 4.4), giving
only a single configuration for the ketones in which the OH group was anti relative to the
heteroatom in the annelated ring. For the reaction in which the carbonyl was an aldehyde,
a minor amount of the syn product was observed. Pendants other than thiophene (e.g.
furan) are able to participate in [4+4] cycloaddition in these conditions, but thiophene
tethers gave only the single [4+2] cycloaddition products. Shown in Figure 4.1 are the
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configurations which we have designated “syn” and “anti.” There are only a few
published examples in which thiophene participates in such a cycloaddition making this
new reaction an exciting development.50 We are happy to report three such cycloaddition
products (7c, 8c, and 9c) formed from the cycloaddition of a tethered thiophene to an
azaxylylene photogenerated via ESIPT.

Figure 4.1: Cycloaddition products and stereochemistry

Scheme 4.4: [4+2] cycloadditions of thiophene to azaxylylenes
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The assembly of these photoprecursors is efficient (all yields > 85% yield), and
with the potential for a large variety of diversity inputs, this photoassisted scheme
provides ready access to polycycles rich in heteroatoms held in rigid spatial
conformations. It is our further goal to submit these compounds to screening for their
potential as drug leads.
We intended to explore a variety of methods for further tranforming the
dihydrothiophene including Povarov conditions. However, the only successful
transformation so far proved to have a surprising result. During irradiation (and under
acidic conditions), 7c undergoes a rearrangement in which the formed vinylic thiol
recombines with the resulting alkene to form 10c (see Scheme 4.5). Surprisingly, treating
8c and 9c with acid was unsuccessful in generating the same rearranged product.

Scheme 4.5: Rearranged product

Scheme 4.6: “Butter-up” synthesis
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After these successes with azaxylylenes, we were incited to explore alternatively
tethered photoprecursors in which the unsaturated dienophile is tethered to the o-acyl
moiety rather than to the amine. We affectionately call these carbonyl-precursors “butterup” (as in: the butter-up side of toast; see Scheme 4.6) This was achieved by coupling 2nitro-2’-bromoacetophenone to 2-furylmethanethiol. The nitro group was then reduced to
the aniline via treatment with tin (II) chloride to give 12c.
In irradiation reactions of “conventionally” tethered azaxylylene precursors, furan
pendants typically react in both a [4+4] and [4+2] fashion, often giving both syn- and
anti- products in various ratios. However, in the 12c, only the [4+4] cycloaddition takes
place (Scheme 4.7), forming the intermediate product 13c. Even more interesting, this
[4+4] was not isolated—and rather only a rearranged [3.3.1] product (14c) is isolable.

Scheme 4.7: “Butter-up” irradiation

The assignment of this structure is based on a similar rearrangement previously
observed by Olga A. Mukhina,49 allowing for a structural determination of 14c by the
analysis of the 1H NMR constants. Typically such a rearrangement is either a minor
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product in irradiation or is implemented via acid catalysis—but in this case, it is the
single product formed immediately during the irradiation. In most of the examples of the
[4+4] cycloaddition with furan, the diastereoselectivity of the product is such that the OH
group is syn to the heteroatom bridge. In acidic conditions, it is thought that the syn OH
group is able to displace the distal end of the (likely protonated, if the conditions are
acidic) O-bridge, resulting in the rearranged product. This mechanism is depicted in
Scheme 4.8.

Scheme 4.8: Rearrangement to [3.3.1]

Mechanistic studies performed by Dmitri Kuznetsov support this mechanism.††
His studies show that when the anti isomer of the shown [4+4] photoproduct is isolated,
its treatment with acid does NOT give the [3.3.1] rearranged product. Thus, for the
rearrangement to occur, the hydroxyl group in the [4+4] cycloaddition product must be
syn to the bridge oxygen.
Attempts to proliferate this reaction scheme (using furfurylamine, acylating or
trifluoroacetylating the aniline, ester or thioester tethered furyl groups, or oxidizing the
sulfur tether to the sulfone) were all unsuccessful (either unable to be synthesized in the
††

These studies are not yet published.
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case of furfurylamine or photoinactive in the other cases mentioned). We did, however,
note an interesting side reaction when attempting to synthesize a cyclic imine from 2bromo-2’-nitroacetophenone with 2-aminoethanethiol. Rather than forming the desired
imine, the major product 15c was formed via the proposed mechanism shown in Scheme
4.9. The structure of 15c is unambiguously proven via X-ray. We propose that after the
nucleophilic sulfur displaces the bromide, the compound cyclizes to form the imine C1.
The enamine tautomer of this compound (C2) is then able to undergo thermal 6
electrocyclization to form C3. In the basic conditions of the reaction, a proton is
eliminated to form the thioester C4. The tautomerization to the imine (driven by
rearomatization) and protonation gives the hydroxylamine (C5) which is oxidized to form
C6. We have not yet identified the oxidant in this reaction mixture, but it is possible that
there is a species which is reduced by C5 in the mixture as there are several species yet
unidentified due to the difficulty in separation. Finally, the intramolecular nucleophilic
attack by the imine on the nitroso group forms the delightfully unexpected 15c.

Scheme 4.9: Unusual product and mechanism
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Experimental Procedures and Data
Common solvents were purchased from Pharmco Aaper and used directly, except
for THF—which was refluxed over and distilled from potassium benzophenone ketyl
prior to use—and hexane—which was distilled over calcium hydride. Common reagents
were purchased from Sigma Aldrich, Acros, or TCI America and used without additional
purification, unless indicated otherwise. NMR spectra were recorded at 25 oC on a Bruker
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an
internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker
APEX II instrument. High resolution mass spectra were obtained on the MDS
SCIEX/Applied Biosystems API QSTARTM Pulsar i Hybrid LC/MS/MS System mass
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at
Boulder. For the 1H,

13

C, COSY NMR spectra which are not included in Appendix B,

see supporting information in ref. [49].

2-((Trimethylsilyloxy)methyl)aniline (1c): A solution of trimethylsilyl
chloride (2.66 g, 24.3 mmol) in dichloromethane (25 mL) was added to a stirred solution
of 2-aminobenzylmethanol (3.00 g, 24.3 mol) and triethylamine (2 eq, 4.92 g, 48.6 mmol)
in dichloromethane (25 mL). The reaction mixture was stirred at 20°C for 24 h. After
that, the mixture was quenched with saturated ammonium chloride solution (20 mL). The
organic layer was separated and the aqueous phase was extracted with dichloromethane.
The combined organic fractions were dried over anhydrous magnesium sulfate, filtered
and the solvent was removed by rotary evaporation. The product (4.30 g, 90%) was used
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without further purification. 1H NMR (500 MHz, CDCl3) δ 7.14 (td, J = 7.7, 1.5, 1H),
7.10-7.06 (m, 1H), 6.74 (td, J = 7.4, 1.1, 1H), 6.71 (d, J = 8.6, 1H), 4.69 (s, 2H), 4.19 (s,
2H), 0.16 (s, 9H).

8-Amino-1-tetralone (2c): 5,6,7,8-Tetrahydro-1-naphthylamine (3.0 g, 21.6
mmol) in ethanol (10 mL, anhydrous) was added dropwise to a solution of acetic
anhydride (4.1 mL, 43.2 mmol) in ethanol (40 mL) at 0°C. The mixture was stirred for 8
h at 20°C. The solvent was removed under vacuum on a rotary evaporator to yield 8acetamidotetralin as a white solid (3.9 g) that was used without further purification. 1H
NMR (500 MHz, CDCl3) δ 7.50 (d, J = 7.7, 1H), 7.15 (br s, 1H), 7.11 (t, J = 7.7, 1H),
6.93 (d, J = 7.6, 1H), 2.78 (t, J = 6.1, 2H), 2.59 (t, J = 6.2, 2H), 2.05 (s, 3H), 1.86-1.73
(m, 4H). 8-Acetamidotetralin (0.50 g, 2.7 mmol) in acetone (15 mL) and 15% aqueous
magnesium sulfate (0.40 g in 2.5mL of water) at 20°C was treated with potassium
permanganate (1.15 g, 7.3 mmol). The mixture was allowed to stir at 20°C for 6 h. The
mixture was filtered through celite and the solids were washed with chloroform and
water. The organic layer was separated and the aqueous layer was extracted several times
with chloroform. The combined organic fractions were washed with brine and dried over
anhydrous magnesium sulfate, filtered and evaporated to give 8-acetamidotetralone (0.47
g, 88%) which was used without further purification. 1H NMR (500 MHz, CDCl3) δ
12.18 (s, 1H), 8.62 (d, J = 8.4, 1H), 7.54-7.41 (m, 1H), 7.01-6.89 (m, 1H), 3.00 (m, 2H),
2.71 (m, 2H), 2.29 (s, 3H), 2.10 (m, 2H). 8-Acetamidotetralone (0.47 g, 2.3 mmol) in 6N
HCl (10mL) was heated at 90°C for 3 h. The mixture was cooled to 20°C and evaporated
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to dryness under vacuum. Ice was added to the mixture followed by addition of 2 M
NaOH until the mixture was at pH 8. The aqueous layer was extracted with EtOAc and
the organic fractions were combined, washed with brine, dried, filtered and concentrated
to give 0.28 g (75%). 1H NMR (500 MHz, CDCl3) δ 7.18 (dd, J = 8.2, 7.3, 1H), 6.65-6.36
(m, 4H), 2.92 (t, J = 6.1, 2H), 2.69 (t, J = 6.1, 2H), 2.07 (m, 2H).

3-(2-Thienyl)-propanoic acid chloride (3c): To a stirred solution of
0.45 g (2.6 mmol) of 3-(2-thienyl)-propanoic acid in 5 mL of dichloromethane, 0.34 g
(2.9 mmol) of thionyl chloride was added and refluxed for 3 h. 0.42 g (93%) of yellowbrown oil. 1H NMR (500 MHz, CDCl3) δ 7.20 (dd, J = 5.1, 1.2, 1H), 6.96 (dd, J = 5.1,
3.5, 1H), 6.88 (m, 1H), 3.28 (m, 4H).

3-(Thien-2-yl)-N-(2-(hydroxymethyl)phenyl)propanamide (4c-1): A
solution of 0.56 g 3c (3.2 mmol) in dry THF (25 mL) was slowly added to a stirred
solution of 0.57 g 1c (2.9 mmol) and 0.25 g dry pyridine (3.2 mmol) in THF (50 mL) at
0°C. After stirring for 10 min the mixture was allowed to warm to 20°C, at which it was
maintained overnight. It was then diluted with water (50 mL), extracted with EtOAc (3 x
50 mL) and dried over anhydrous Na2SO4. Upon concentration, the crude product was
purified by flash chromatography. 0.67 g (71%) yield. 1H NMR (500 MHz, CDCl3) δ
8.56 (br s, 1H), 7.94 (d, J = 8.2, 1H), 7.29 (td, J = 7.8, 1.5, 1H), 7.16-7.11 (m, 2H), 7.06
(t, J = 7.4, 1H), 6.91 (dd, J = 5.1, 3.5, 1H), 6.84 (d, J = 3.0, 1H), 4.54 (s, 2H), 3.23 (t, J =
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7.4, 2H), 2.81-2.73 (br s,1H), 2.70 (t, J = 7.4, 2H). 13C NMR (126 MHz, CDCl3) δ 195.5,
171.9, 141.0, 136.2, 136.0, 133.6, 131.7, 122.8, 121.6, 119.9, 44.7, 42.5, 31.9, 29.7.

N-(2-Acetylphenyl)-3-(thien-2-yl)propanamide (5c): A solution of
0.11 g 3c (0.62 mmol) in dry THF (5 mL) was slowly added to a stirred solution of 0.08 g
2-aminoacetophenone (0.60 mmol) and 0.05 g dry pyridine (0.62 mmol) in THF (50 mL)
at 0°C. After stirring for 10 min the mixture was allowed to warm to 20°C, at which it was
maintained overnight. It was then diluted with water (50 mL), extracted with EtOAc (3 x
50 mL) and dried over anhydrous Na2SO4. Upon concentration, the crude product was
purified by flash chromatography. 0.14 g (88%). 1H NMR (500 MHz, CDCl3) δ 11.66 (s,
1H), 8.66 (d, J = 8.5, 1H), 7.77 (dd, J = 8.0, 1.5, 1H), 7.44 (ddd, J = 8.7, 7.2, 1.5, 1H),
7.03-6.98 (m, 2H), 6.80 (dd, J = 5.0, 3.5, 1H), 6.78-6.76 (m, 1H), 3.18 (t, J = 7.6, 2H),
2.71 (t, J = 7.6, 2H), 2.54 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 202.9, 171.0, 143.2,
140.9, 135.2, 131.7, 126.9, 124.8, 123.5, 122.4, 121.8, 120.8, 40.2, 28.6, 25.5. HRMS
(ESI) calcd for C15H15NNaO2S+ (MNa+) 296.0716, found 296.0706.

3-(Thien-2-yl)-N-(2-formylphenyl)propanamide (4c): To a wellstirred solution of 0.27 g 4c-1 (1.1 mmol) in dichloromethane (25 mL) at ambient
temperature, a suspension of pyridinium chlorochromate (0.34 g, 1.6 mmol) in
dichloromethane (10 mL) was added. The reaction mixture was left stirring overnight and
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then filtered through a layer of silica gel affording the pure product. 0.31 g (91%). 1H
NMR (500 MHz, CDCl3) δ 11.17 (s, 1H), 9.90 (s, 1H), 8.76 (d, J = 8.3, 1H), 7.66 (dd, J =
7.7, 1.6, 1H), 7.61 (ddd, J = 8.7, 7.1, 1.6, 1H), 7.23 (td, J = 7.5, 0.9, 1H), 7.13 (dd, J =
5.2, 1.1, 1H), 6.91 (dd, J = 5.1, 3.5, 1H), 6.89-6.86 (m, 1H), 3.30 (t, J = 7.6, 2H), 2.84 (t,
J = 7.6, 2H). 13C NMR (126 MHz, CDCl3) δ 195.6, 171.1, 143.0, 140.8, 136.3, 136.1,
126.9, 124.8, 123.6, 123.0, 121.6, 120.0, 40.0, 25.4. HRMS (ESI) calcd for
C14H13NNaO2S+ (MNa+) 282.0559, found 282.0562.

N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)-3-(thiophen-2-yl)
propanamide (6c): A solution of 0.50 g 3c (2.9 mmol) in dry THF (5 mL) was slowly
added to a stirred solution of 0.46 g 2c (2.9 mmol) and 0.45 g dry pyridine (5.7 mmol) in
THF (50 mL) at 0°C. After stirring for 10 min the mixture was allowed to warm to 20°C,
at which it was maintained overnight. It was then diluted with water (50 mL), extracted
with EtOAc (3 x 50 mL) and dried over anhydrous Na2SO4. Upon concentration, the
crude product was purified by flash chromatography. 0.74 g, 87%. 1H NMR (500 MHz,
CDCl3) δ 12.25 (s, 1H), 8.65 (d, J = 8.5 Hz, 1H), 7.47 (t, J = 8.0 Hz , 1H), 7.14 (dd, J =
5.1, 1.2 Hz, 1H), 6.96 (dd, J = 7.6, 1.0 Hz, 1H), 6.93 (J = 5.1, 3.5 Hz, 1H), 6.89 (ddd, J =
3.3, 1.0, 1.0, 1H), 3.32 (t, J = 7.4 Hz, 2H), 2.99 (t, J = 6.1 Hz, 2H), 2.85 (t, J = 8.1 Hz,
2H), 2.71 (t, J = 6.2 Hz, 2H), 2.11 (ddd, J = 12.7, 6.4, 6.4 Hz, 2H).
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1-Aza-2,3-benzo-4-hydroxy-4-methyl-8-thiatricyclo[7.3.0.05,9]dodeca-2,6-dien-12-one (8c): 0.10 g (0.37 mmol) of 5c was dissolved
in 50 mL toluene, heated to reflux and irradiated in a Pyrex reaction vessel in a Rayonet
reactor equipped with RPR-3500 UV lamps (broadband 300-400 nm UV source with
peak emission at 350 nm) until the reaction was complete. Upon flash chromatography
0.06 g (60%) of the product was obtained. 1H NMR (500 MHz, CDCl3) δ 7.72 (dd, J =
7.9, 1.1, 1H), 7.40 (td, J = 8.0, 1.4, 1H), 7.36 (dd, J = 7.7, 1.4, 1H), 7.21 (td, J = 7.7, 1.3,
1H), 6.11 (dd, J = 6.7, 2.7, 1H), 5.09 (dd, J = 6.7, 2.5, 1H), 3.91 (t, J = 2.6, 1H), 2.892.80 (m, 2H), 2.76-2.67 (m, 1H), 2.58-2.52 (m, 1H), 1.84 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 171.8, 134.9, 134.6, 129.2, 127.2, 125.8, 124.6, 124.5, 118.5, 84.5, 71.8, 68.8,
40.2, 31.3, 26.2. HRMS (ESI) calcd for C15H15NNaO2S+ (MNa+) 296.0716, found
296.0713.

1-Aza 2,3-benzo-4-hydroxy-8-thia-tricyclo[7.3.0.05,9]dodeca-2,6-dien12-one (7c): 0.21 g (0.81 mmol) of 4c was dissolved in 120 mL acetonitrile and
irradiated in a Pyrex reaction vessel in a Rayonet reactor equipped with RPR-3500 UV
lamps (broadband 300-400 nm UV source with peak emission at 350 nm) until the
reaction was complete. Upon flash chromatography 0.13 g (64%) of the product was
obtained. 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.1, 1.1, 1H), 7.42 (dt, J = 7.7, 1.7,
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1H), 7.24 (dd, J = 7.4, 1.6, 1H), 7.19 (dt, J = 7.5, 1.2, 1H), 6.12 (dd, J = 6.6, 2.7, 1H),
5.11 (dd, J = 6.6, 2.5, 1H), 4.92 (br s, 1H), 4.05 (q, J = 2.6, 1H), 2.88-2.52 (m, 5H). 13C
NMR (126 MHz, CDCl3) δ 171.9, 134.7, 132.1, 129.7, 128.4, 127.1, 126.0, 124.1, 119.1,
84.2. 70.7, 63.7, 40.1, 31.4. HRMS (ESI) calcd for C14H13LiNO2S+ (MLi+) 266.0822,
found 266.0832.

(31SR,13aSR,13bSR)-13a-hydroxy-4,5,11,12,13,13a-hexahydrobenzo
[de]pyrrolo[1,2-a]thieno[2,3-b]quinolin-6(13bH)-one (9c): 0.12 g (0.40 mmol) of 6c
was dissolved in 50 mL aqueous methanol (5% H2O by volume) and irradiated in a Pyrex
reaction vessel in a Rayonet reactor equipped with RPR-3500 UV lamps (broadband 300400 nm UV source with peak emission at 350 nm) for 6 h. Upon flash chromatography
75 mg (64%) of the product was obtained.

1

H NMR (500 MHz, CDCl3) δ 7.56 (d, J =

7.6, 1H), 7.30 (t, J = 7.8 Hz, 1H), 7.01 (d, J = 7.8Hz), 6.16 (dd, J = 6.7, 2.7 Hz, 1H), 5.21
(dd, J = 6.6, 2.6 Hz, 1H), 3.93 (t, J = 2.7 Hz, 1H), 2.91-2.83 (m, 2H), 2.93-2.69 (m, 3H),
2.57 (ddd, J = 16.8, 7.5, 2.2 Hz, 1H), 2.19 (s, 1H), 2.13 (m, 1H), 2.04 (dt, J = 15.8, 3.8,
1H), 1.95-1.83 (m, 2H).

13

C NMR (126 MHz, CDCl3) δ 172.0, 137.9, 134.3, 129.9,

128.4, 126.8, 126.5, 121.9, 118.9, 84.7, 70.3, 67.0, 40.3, 36.3, 31.3, 29.6, 19.0.

1-Aza-10,11-benzo-9-hydroxy-5-thia-tricyclo
[6.3.1.04,12]dodeca-6,10-dien-2-one (10c): 0.21 g (0.81 mmol) of 4c was dissolved in
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120 mL acetonitrile and irradiated in a Pyrex reaction vessel in a Rayonet reactor
equipped with RPR-3500 UV lamps (broadband 300-400 nm UV source with peak
emission at 350 nm) for 6 h. Upon flash chromatography 80 mg (28%) of the product was
obtained.

1

H NMR (500 MHz, CDCl3) δ 8.89 (d, J = 8.5 Hz, 1H), 7.43-7.86 (m, 2H),

7.14 (t, J = 6.6 Hz, 1H), 6.24 (dd, J = 9.9, 3.1 Hz, 1H), 5.31 (dd, J = 9.9, 2.8 Hz, 1H),
4.85-4.82 (m, 2H), 3.00 (t, J = 6.2 Hz, 1H), 3.54 (br s. 1H), 3.17 (dd, J = 17.0, 6.6 Hz,
1H), 2.87 (dt, J = 6.2, 2.8. 2.8 Hz, 1H), 2.65 (d, J = 17 Hz, 1H), 1.95 (d, J = 2.8 Hz). 13C
NMR (126 MHz, CDCl3) δ 172.1, 135.9, 130.2, 130.1, 124.5, 123.8, 123.6, 118.6, 117.9,
70.6, 54.6, 43.1, 36.5, 35.2. HRMS (ESI) calcd for C14H13LiNO2S+ (MLi+) 266.0822,
found 266.0832.

1-(2-Aminophenyl)-2-(furan-2-ylmethylthio)ethanone

(12c):

2.24 g of 2-bromo-2’nitroacetophenone (9.2 mmol) was dissolved in 30 mL
dichloromethane along with 1.08 g 2-furylmercaptan (9.2 mmol) and 1.48 g dry pyridine
(18.4 mmol) for 1h before quenching the reaction with 5% HCl solution (10 mL),
extracting the aqueous layer with dichloromethane (2 x 20 mL), combining the organic
layers and drying them over anhydrous sodium sulfate. The organic layer was then
decanted and concentrated to give the pure product (11c). 2.50 g (98%). This was then
dissolved in 100 mL ethanol along with 5.23 g tin (II) chloride (27.0 mmol) and heated to
70oC under nitrogen atmosphere for 2h. Saturated sodium bicarbonate solution was added
slowly until the pH of the mixture was 8, giving a thick milky white emulsion. This was
filtered through celite and the filtrate was extracted with EtOAc (3 x 100 mL). The
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organic phase was washed with brine (2 x 50 mL) and the organic layer was then dried
over anhydrous sodium sulfate. The solvent was removed under reduced pressure and the
crude product was purified by flash chromatography. 1.76 g (78%) yield.

1

H NMR (500

MHz, CDCl3) δ 7.67 (dd, J = 8.2, 1.0 Hz, 1H), 7.40 (d, J = 1.8, 0.7 Hz, 1H) 7.30 (dt J =
8.4, 1.3 Hz 1H), 6.69 (d, J = 8.4 Hz, 1H), 6.15 (dt J = 8.2, 1.0, 1H) 6.37-6.26 (m, 4H),
3.85 (s, 2H), 3.83 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 196.7, 151.1, 150.7, 142.4,
134.8, 131.4, 117.5, 116.3, 115.8, 110.4, 108.4, 37.6, 28.5. HRMS (ESI) calcd for
C13H14NO2S+ (MH+) 248.0740, found 248.0743.

9-Aza-10,11-Benzo-5-Hydroxy-2-oxa-3-thiatricyclo[6.3.1.04,12]dodeca-6,10-diene (14c) 0.31 g of 12c was dissolved in 50 mLwet
acetonitrile (5% H2O by volume) and irradiated in a Pyrex reaction vessel in a Rayonet
reactor equipped with RPR-3500 UV lamps (broadband 300-400 nm UV source with
peak emission at 350 nm) for 2h. The irradiation solution was concentrated under reduced
pressure and purified via flash chromatography. 0.28 g (89%).

1

H NMR (500 MHz,

CDCl3) δ 8.32 (dd, J = 8.1, 1.3 Hz, 1H), 7.24, (dt, J = 8.1, 1.5 Hz, 1H), 6.97 (dt, J = 8.1,
1.3 Hz, 1H), 6.76, (dd, J = 8.0, 1.2 Hz, 1H), 6.31 (d, J = 9.8 Hz, 1H), 5.63 (dd, J = 9.8,
3.2 Hz, 1H), 5.50 (ddd, J = 5.0, 3.4, 0.6 Hz, 1H), 4.60-4.55 (m, 1H), 3.38 (d, J = 9.8 Hz),
3.07 (m, 2H), 2.91 (d, J = 9.8 Hz, 1H), 2.85 (t, J = 1.4 Hz, 1H).

13

C NMR (126 MHz,

CDCl3) δ 196.7, 151.1, 150.7, 142.4, 134.8, 131.4, 117.5, 116.3, 115.8, 110.4, 108.4,
37.6, 28.5. HRMS (ESI) calcd for C13H14NO2S (MH+) 248.0740, found 248.0739.
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1-oxo-3,4-dihydro-[1,4]thiazino[4,3-b]indazol5-ium-6(1H)-olate (15c): 0.2g 2-bromo-2'-nitroacetophenone (0.8 mmol) was stirred in
10mL THF along with 2-aminoethanethiol (0.06g, 0.05mL, 0.8 mmol) and 0.12g (1.23
mmol) triethylamine at ambient temperature for 12h.

The reaction mixture was

concentrated under reduced pressure to remove THF, diluted with 10 mL EtOAc, and
washed with saturated sodium bicarbonate solution (3 x 5 mL) and water (3 x 5 mL). The
organic layer was then dried over anhydrous sodium sulfate and purified via flash
chromatography. 0.11g (61%). 1H NMR (500 MHz, CDCl3) δ 8.25 (dt, J = 8.4, 1.0, 1.0
Hz, 1H), 7.85 (dt, J = 8.7, 1.0, 1.0 Hz, 1H), 7.50 (ddd, J = 8.4, 7.0, 1.0 Hz, 1H), 7.45
(ddd, J = 8.4, 7.0, 1.0 Hz, 1H), 4.86 (ddd, J = 5.8, 3.7, 2.2 Hz, 2H), 3.64 (ddd, J = 5.8,
3.7, 2.2 Hz, 2H). HRMS (ESI) calcd for C10H8N2O2SNa (MNa+) 243.0199, found
243.0200.
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Imine-Type Azaxylelenes
Results and Discussion
An additional diversity input considered for this excited-state intramolecular
proton transfer (ESIPT) azaxylylene system was to vary the moiety which abstracts the
proton from the ortho nitrogen. This thought led us to consider imines. Currently, there
are no published examples of imines participating in ESIPT reactions. We discovered that
while imines reacted more slowly than aldehydes or ketones, they did indeed react to
generate an azaxylylene and were successfully able to participate in both [4+4] and [4+2]
cycloaddition reactions. The products of these reactions were secondary amines which
could potentially be used in subsequent post-photochemical modifications.
Several approaches were attempted in the effort to utilize an imine as the proton
acceptor in the ESIPT manifold. Initially it was hoped that we could achieve this by
simply converting

our

first-generation

azaxylylene

scaffolds

(Scheme

4.10).

Unfortunately, all imines of this type were inert in photochemical conditions. We posit
that while it is likely that the imine is being promoted to the excited state, the free
rotation of the R group assists in dissipating the energy, preventing any ESIPT from
happening. In fact, in some cases, the imine was hydrolyzed back into the aldehyde,
giving a nice photoproduct, but one which had already been thoroughly studied and
characterized by my colleague, Olga A. Mukhina (see ref. 49).
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Scheme 4.10: Imines, dissipation of energy via rotation

Our next approach was to design an imine which would be unable to rotate in
such a fashion. For this approach, we employed the synthesis scheme of Kuo and Wu51
which gave 16c (Scheme 4.11). While this imine was synthesized and coupled to furyl
and norbornyl pendants, photoprecursors of this type had a handicap from the start. Olga
Mukhina’s study in the irradiation of benzophenone-type photoprecursors coupled to
furan tethers in this fashion were extraordinarily slow—nearly prohibitively so.49
Attempts to improve the reactivity for the imines of a similar structure by changing the
conditions (differing solvents, HMPA addition, heat, long irradiation times), did not
prove fruitful. In fact, some of the precursors degraded completely during irradiation with
no evidence of the desired product formed.

Scheme 4.11: Benzophenone-type imines
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Since the imine in this azaxylylene precursor could neither be freely rotating nor
tethered to an “extra” aromatic ring, we endeavored to design aliphatic cyclic imines
which could be coupled to unsaturated pendants. In this effort, we were successful. The
first cyclic imine was synthesized via an ortho-directed Friedel-Crafts acylation of aniline
with 4-chlorobutyronitrile. The nucleophilic displacement of the chloride with azide
provided a good setup for an aza-Wittig reaction, furnishing the desired imine (Scheme
4.12).52

Scheme 4.12: Cyclic aliphatic imine synthesis

This imine was tethered to the unsaturated pendant that the Kutateladze group’s
research49 has shown to be the most reactive: 3-(2-furyl)-propanoic acid chloride (17c).
Successful coupling and optimization of irradiation conditions furnished the [4+4] and
[4+2] cycloaddition products (19c and 20c, respectively) in approximately 1:1 ratio
(Scheme 4.13).

Scheme 4.13: Synthesis and irradiation of cyclic imine 18c
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Unfortunately, the irradiation of a similar cyclic imine with a 6-membered ring
was unsuccessful. Instead, we tethered the derivatives of 5-chlorovaleronitrile (the
precursor for the 6-membered imine) to bromoacetyl bromide, displaced the resulting
bromide with benzylamine, then furoylated the secondary amine to get the
photoprecursor as either the azide or the chloride. The design of this type of pendant arm
was first established by the Kutateladze group member Bhuvan Nandipati.49 When the
ESIPT agent is a carbonyl, the furoyl pendants predominately added to the
photogenerated azaxylylenes in a [4+4] fashion. In the case of the chloride 24c and azide
25c, the exclusive photoproducts are 26c and 27c respectively (Scheme 4.14). Their
structures were proven via X-ray crystallographic analysis. These “linker” type
compounds have the potential for diversification via either nucleophilic displacement of
the chloride or via click chemistry in the azide. Cyclizing the azide via the aza-Wittig into
the 6-membered cyclic imine was successful, but the compound was not photochemically
active. While this pathway did not prove fruitful for the application of imines in the
ESIPT photogeneration of azaxylylenes, it is our hope that the high-yielding synthesis of
this scaffold be useful as a tether—perhaps in the attempt to immobilize this scaffold for
solid-state syntheses.
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Scheme 4.14: Synthesis and irradiation of “linker” products

Diversions aside, our next endeavor was in the synthesis of a cyclic imine derived
from isatin. In this reaction, isatin both opened to form the aniline and cyclized to form
the desired imine (28c) upon treatment with N-methylethylenediamine and anhydrous
magnesium sulfate. This was coupled to 17c to furnish 29c. Its irradiation gave the
desired [4+4] and [4+2] cycloaddition products in approximately 1:1 ratio (30c and 31c
respectively; Scheme 4.15).
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Scheme 4.15: Photoproducts of the cyclic imine derived from isatin

It is evident that the application of cyclic imines as the proton abstracting
component in the ESIPT azaxylylene generation and cycloadditions is in its infancy. The
use of cyclic imines in this sequence serves to increase the structural diversity of the
polyheterocyclic scaffolds in both heteroatom saturation and skeletal structures available
from the photoassisted generation of azaxylylenes in their intramolecular cycloadditions.

Experimental Procedures and Data
Common solvents were purchased from Pharmco Aaper and used directly, except for
THF—which was refluxed over and distilled from potassium benzophenone ketyl prior to
use—and hexane—which was distilled over calcium hydride. Common reagents were
purchased from Sigma Aldrich, Acros, or TCI America and used without additional
purification, unless indicated otherwise. NMR spectra were recorded at 25 oC on a Bruker
Avance III 500 MHz or Varian Mercury 400 MHz instrument in CDCl3 with TMS as an
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internal standard (unless noted otherwise). X-Ray structures were obtained with a Bruker
APEX II instrument. High resolution mass spectra were obtained on the MDS
SCIEX/Applied Biosystems API QSTARTM Pulsar i Hybrid LC/MS/MS System mass
spectrometer by Dr. Shuji Kato or Dr. Dan Gu from the University of Colorado at
Boulder. For the 1H,

13

C, COSY NMR spectra which are not included in Appendix B,

see supporting information in ref. [49].

3-(2-Furyl)-propanoic acid chloride (17c): To a stirred solution of
0.73 g (4.6 mmol) of 3-(2-furyl)-propanoic acid in 10 mL of dichloromethane, 0.60 g
(5.1 mmol) of thionyl chloride was added and refluxed for 3 h. 0.65 g (89%) of yellowbrown oil. 1H NMR (500 MHz, CDCl3) δ 7.35 (br s, 1H), 6.32 (br s, 1H), 6.10 (br s, 1H),
3.27 (t, J = 7.1, 2H), 3.06 (t, J = 7.1, 2H).

N-(2-(3,4-dihydro-2H-pyrrol-5yl)phenyl)-3-(furan-2-yl)propanamide (18c): 0.30g of the 18c-1 (1.87 mmol), 0.30 g of
17c (1.87 mmol), and 0.25 g triethylamine (2.43 mmol, 1.3 equiv) were stirred at ambient
temperature in freshly distilled THF for 2 h. The solvent was then removed, the residue
dissolved in ethyl acetate (25 mL), and washed with saturated sodium bicarbonate (2 x 15
mL) and brine (1 x 15 mL). The organic layers were combined and dried over anhydrous
sodium sulfate, concentrated, and purified via silica gel chromatography to give 0.43 g of
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the product (82%). 1H NMR (500 MHz, CDCl3) δ 13.31 (br. s, 1H), 8.80 (dd, J = 8.3, 1.0,
1H), 7.55 (dd, J = 7.9, 1.5, 1H), 7.43 (dt, J = 7.9, 7.9, 1.5, 1H), 7.34 (dd, J = 1.8, 0.7,
1H), 7.10 (dt, J = 7.7, 7.7, 1.2, 1H), 6.30 (dd, J = 3.2, 1.9, 1H), 6.11-6.09 (m, 1H), 4.17
(tt, J = 9.2, 7.2, 1.8, 2H), 3.12 (t, J = 7.6, 2H), 3.10-3.05 (m, 2H), 2.81-2.77 (m, 2H),
2.05-1.97 (m, 2H).

13

C NMR (126 MHz, CDCl3) δ 175.4, 171.1, 154.8, 141.1, 140.1,

131.4, 130.3, 122.2, 120.0, 119.4, 110.2, 105.2, 61.4, 36.7, 36.4, 23.9, 21.3.

5-Aza-6,7-benzo-12-oxa-9-spiropyrrolidinotricyclo[7.2.1.01,5]dodeca-6,11-dien-4-one (19c): 0.11 g of 18c (0.39 mmol) was
dissolved in aqueous methanol (5% water by volume), and irradiated in the RPR-3500 for
48 h. Two major products were observed in 1:1 ratio by NMR integration. After flash
chromatography purification on silica gel using a gradient of 0%-100% ethyl acetate in
hexanes, 37 mg (34%). 1H NMR (500 MHz, CDCl3) δ 7.44 (dd, J = 8.1, 1.6, 1H), 7.41
(dd, J = 8.1, 1.4, 1H), 7.37 (td, J = 7.3, 1.5, 1H), 6.35 (dd, J = 5.8, 1.6, 1H), 5.84 (dd, J =
5.8, 1.4, 1H), 4.66 (t, J = 1.4, 1H), 4.15-4.09 (m, 1H), 3.39-3.32 (m, 1H), 2.98-2.89 (m,
1H), 2.75-2.65 (m, 2H), 2.60-2.51 (m, 1H), 2.45 (ddd, J = 13.8, 9.4, 1.7, 1H), 2.22-2.15
(m, 3H).

13

C NMR (126 MHz, CDCl3) δ 172.9, 162.4, 134.2, 130.8, 128.8, 128.7, 128.4,

127.1, 103.3, 87.4, 72.0, 44.0, 38.4, 30.0, 29.7, 28.3, 23.9.
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(2’SR)-2,3-dihydrospiro[furo[2,3-b]pyrrolo[1,2-a]quinoline-7,2'pyrrolidin]-1(6aH)-one (20c): 0.11 g of 18c (0.39 mmol) was dissolved in aqueous
methanol (5% water by volume), and irradiated in the RPR-3500 for 48 h. Two major
products were observed in 1:1 ratio by NMR integration. After flash chromatography
purification on silica gel using a gradient of 0%-100% ethyl acetate in hexanes, 44 mg
(40%).

1

H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.0, 1H), 7.34 (ddd, J = 7.8, 6.5, 2.5,

1H), 7.21-7.15 (m, 2H), 6.23 (t, J = 2.8, 1H), 4.63 (dd, J = 2.9, 2.3, 1H), 3.63 (t, J = 2.3,
1H), 2.99 (ddd, J = 10.2, 7.9, 5.0, 1H), 2.87 (ddd, J = 16.7, 10.5, 8.6, 1H), 2.80 (ddd, J =
10.2, 8.6, 6.5, 1H), 2.60-2.43 (m, 4H), 2.10-1.82 (m, 5H).

1-(2-aminophenyl)-5-chloropentan-1-one

(21c):

Boron

trichloride (1 M in dichloromethane, 15 mL, 15 mmol) was diluted with dichloroethane
(50 mL) and cooled to 0oC. Aniline (2.50 g, 26.8 mmol) was added dropwise and the
solution was allowed to stir at 0oC for 10 min. 5-Chlorovaleronitrile (3.20 g, 27.2 mmol)
was added, followed by aluminum chloride (4.00 g, 30.0 mmol) and the solution was
allowed to warm to ambient temperature. After 10 minutes, the reaction mixture was
heated at reflux for 3 h. The solution was allowed to cool to ambient temperature, 2 M
HCl (15 mL) was added, and the reaction mixture was heated at reflux for 30 min. The
reaction mixture was then diluted with water (20 mL) extracted with dichloromethane (3
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x 20 mL), the combined organic layers washed with brine (25 mL) and dried over
anhydrous sodium sulfate. Concentrating the organic layers then purifying via flash
chromatography on silica gel using a gradient of 0%-100% ethyl acetate in hexanes, the
pure product was recovered. 3.35 g (55%). 1H NMR (500 MHz, CDCl3) δ 7.76 (dd, J =
8.6, 1.6, 1H), 7.29 (dt, J = 8.3, 1.6, 1H), 6.70-6.65 (m, 2H), 6.35-6.25 (br. s, 2H), 3.643.60 (m, 2H), 3.03-2.99 (m, 2H), 1.94-1.88 (m, 4H).

13

C NMR (126 MHz, CDCl3) δ

202.0, 150.4, 134.3, 131.1, 117.8, 117.4, 115.8, 44.8, 38.2, 32.2, 22.0.

1-(2-aminophenyl)-5-azidopentan-1-one (21c-1): 2.81 g of the
21c (13.3 mmol) was dissolved in 150 mL DMF along with 1.20 g sodium azide (18.5
mmol) and a catalytic amount of sodium iodide. This was heated to 100 oC and kept at
that temperature for 8h before it was filtered and concentrated. After flash
chromatography purification on silica gel using a gradient of 0%-100% ethyl acetate in
hexanes, the pure product was recovered. 2.26 g (78%). 1H NMR (500 MHz, CDCl3) δ
7.76 (dd, J = 8.7, 1.6, 1H), 7.31-7.27 (m, 1H), 6.72-6.65 (m, 2H), 6.34-6.27 (br. s, 2H),
3.36 (t, J = 7.0, 2H), 3.01 (t, J = 7.0, 2H), 1.88-1.79 (m, 2H), 1.75-1.68 (m, 2H).

13

C

NMR (126 MHz, CDCl3) δ 201.9, 150.4, 134.3, 131.1, 117.8, 117.4, 115.8, 51.4, 38.4,
28.6, 21.8.

2-(3,4,5,6-tetrahydropyridin-2-yl)aniline (21c-2): 2.48 g of the 21c-1
(11.4 mmol) was dissolved in 100 mL DMF along with 3.27 g triphenylphosphine (12.5
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mmol). This was heated to 100oC and kept at that temperature for 2 h before it was
cooled to ambient temperature and concentrated. After flash chromatography purification
on silica gel using a gradient of 0%-100% ethyl acetate in hexanes, the pure product was
recovered. 1.75 g (88%). 1H NMR (500 MHz, CDCl3) δ 7.49 (dd, J = 7.9, 1.4, 1H), 7.12
(dt, J = 8.4, 1.6, 1H), 6.69-6.64 (m, 2H), 6.61-6.52 (br. s, 2H), 3.88 (tt, J = 7.6, 5.9, 1.8,
2H), 2.68 (tt, J = 8.5, 6.6, 1.8, 2H), 1.88-1.82 (m, 2H), 1.71-1.65 (m, 2H).

13

C NMR (126

MHz, CDCl3) δ 168.0, 148.2, 129.5, 128.1, 120.6, 116.9, 115.8, 49.0, 27.6, 21.8, 20.1.

3-(furan-2-yl)-N-(2-(3,4,5,6-tetrahydropyridin-2-yl)phenyl)
propanamide (21c-3): 0.31 g of the 21c-2 (1.78mmol), 0.28 g of 17c (1.78mmol), and
0.23 g triethylamine (2.31 mmol, 1.3eq) were stirred at ambient temperature in freshly
distilled THF for 2 h. The solvent was then removed, the residue dissolved in ethyl
acetate (25 mL), and washed with saturated sodium bicarbonate (2 x 15 mL) and brine (1
x 15 mL). The organic layers were combined and dried over anhydrous sodium sulfate,
concentrated, and purified via silica gel chromatography to give 0.44 g of the product
(84%). 1H NMR (500 MHz, CDCl3) δ 8.72 (dd, J = 8.4, 1.2, 1H), 7.62 (dd, J = 7.9, 1.6,
1H), 7.37 (td, J = 8.4, 1.4, 1H), 7.34 (dd, J = 1.8, 0.8, 1H), 6.30 (dd, J = 3.1, 2.0, 1H),
6.10-6.08 (m, 1H), 3.91 (ddd, J = 7.8, 5.8, 2.0, 2H), 3.11 (t, J = 7.1, 2H), 2.76-2.69 (m,
4H), 1.91-1.85 (m, 2H), 1.75-1.69 (m, 2H).

13

C NMR (126 MHz, CDCl3) δ 170.7, 168.9,

154.8, 141.1, 139.6, 130.6, 127.5, 123.4, 122.1, 120.6, 110.2, 105.3, 48.8, 36.9, 27.8,
24.0, 21.4, 19.8.
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2-bromo-N-(2-(5-chloropentanoyl)phenyl)acetamide (22c): 0.59
g of 21c (2.8 mmol) was stirred in 25 mL dichloromethane along with 0.56 g
bromoacetyl bromide (2.8 mmol) in the presence of 0.28 g dry pyridine (3.6 mmol). This
was allowed to stir at ambient temperature for 20 min before it was washed with
saturated sodium bicarbonate (2 x 10 mL) and the organic layer dried over anhydrous
sodium sulfate then concentrated. Purification via flash chromatography gave the pure
product. 0.88 g (94%). 1H NMR (500 MHz, CDCl3) δ 12.33 (s, 1H), 8.74 (dd, J = 8.5,
1.0 Hz, 1H), 7.98 (dd, J = 8.0, 1.5 Hz, 1H), 7.62 (dt, J = 7.4, 7.4, 1.4 Hz, 1H), 7.22 (dt, J
= 7.4, 7.4, 1.2 Hz, 1H), 4.05 (s, 2H), 3.63 (t, 6.2 Hz, 2H), 3.12 (t, J = 6.7 Hz, 2H), 1.991.87 (m, 4H).

13

C NMR (126 MHz, CDCl3) δ 203.9, 165.4, 140.0, 135.0, 130.6, 122.4,

122.3, 121.1, 44.6, 39.0, 29.6, 21.8.

N-benzyl-N-(2-(2-(5-chloropentanoyl)phenylamino)-2oxoethyl)furan-2-carboxamide (24c): 0.38 g of 22c (1.1 mmol) was dissolved in
anhydrous dichloromethane (25 mL) along with 0.16 g benzylamine (1.4 mmol) and 0.32
g DIPEA (2.5 mmol). This was allowed to stir at ambient temperature for 8 h, then it was
washed with saturated sodium bicarbonate (2 x 10 mL), and the organic layer was dried
over anhydrous sodium sulfate to give 23c. The organic layer was decanted from the
sodium sulfate and then 0. 17 g 2-furoyl chloride (1.8 mmol)was added along with 0.24 g
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DIPEA (1.9 mmol). This was stirred at ambient temperature for 8 h then washed with
saturated sodium bicarbonate (2 x 10 mL) and the organic layer dried over anhydrous
sodium sulfate then concentrated. Purification via flash chromatography gave the pure
product. 0.38 g (77%). 1H NMR (500 MHz, CDCl3) δ 12.22 (s, 1H), 8.78 (dd, J = 8.5, 1.0
Hz, 1H), 7.93 (d, J = 8.0, 1H), 7.58 (t, J = 7.7 Hz, 1H), 7.51 (s. 1H), 7.43-7.30 (m, 5H),
7.22 (s, 1H), 7.17 (t, J = 7.3 Hz, 1H), 6.52 (s, 1H), 5.07 (br s, 2H), 4.30 (br s, 2H), 3.57
(ddd, J = 6.6, 3.2, 3.2 Hz, 2H), 3.06 (ddd, J = 6.7, 3.6, 3.6, 2H), 1.90-1.78 (m, 4H).

N-(2-(2-(5-azidopentanoyl)phenylamino)-2-oxoethyl)-Nbenzylfuran-2-carboxamide (25c): 2.08 g of 24c (4.6 mmol) was stirred in 20 mL DMF
along with 0.30 g sodium azide (4.6 mmol) and then heated to 100oC for 6 h. The
reaction mixture was concentrated under vacuum and then purified via flash
chromatography to furnish the pure product. 1.92 g (91%). 1H NMR (500 MHz, CDCl3) δ
12.20 (s, 1H), 8.79 (d, J = 8.5 Hz, 1H), 7.93 (d, J = 7.8, 1H), 7.59 (t, J = 7.3 Hz, 1H),
7.51 (s. 1H), 7.43-7.30 (m, 5H), 7.21 (s, 1H), 7.17 (t, J = 7.5 Hz, 1H), 6.52 (s, 1H), 5.07
(br s, 2H), 4.30 (br s, 2H), 3.32 (D, J = 6.8 Hz, 2H), 3.06 (d, J = 7.0, 2H), 1.77 (p, J = 7.2
Hz, 2H), 1.77 (p, J = 7.2 Hz, 2H).
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syn-9-Hydroxy-9-(4-chlorobutyl)-3-Nbenzyl-7,8-benzo-13-oxa-3,6-diazatricyclo[8.2.1.01,6]

trideca-7,11-diene-2,5-dione

(26c): 0.24g of 24c (0.53 mmol) was dissolved in 20 mL aqueous methanol (5% H2O by
volume) and irradiated for 4 h. The mixture was then concentrated and purified via flash
chromatography. 0.21 g (89%). 1H NMR (500 MHz, CDCl3) δ 7.45-7.31 (m, 8H), 7.167.12 (m, 1H), 6.25 (dd, J = 6.0, 1.8 Hz, 1H), 5.95 (dd, J = 6.0, 0.7 Hz, 1H), 5.07 (dd, J =
1.8, 0.7 Hz, 1H), 4.97 (d, J = 14.7 Hz, 1H), 4.55 (d, J = 14.5 Hz, 1H), 4.34 (d, J = 18.2
Hz, 1H), 4.09 (d, J = 18.2 Hz, 1H), 3.66 (ddd, J = 21.1, 10.9, 6.4 Hz, 2H), 3.15 (br. s,
1H), 2.20 (ddd, J = 14.0, 12.0, 4.9 Hz, 2H), 2.08 (ddd, J = 13.9, 11.8, 4.7 Hz, 2H), 2.021.93 (m, 2H), 1.82-1.77 (m, 1H).

syn-9-Hydroxy-9-(4-azido)-3-Nbenzyl-7,8-benzo-13-oxa-3,6-diazatricyclo[8.2.1.01,6]

trideca-7,11-diene-2,5-dione

(27c): 0.31 g of 25c (0.67 mmol) was dissolved in 20 mL aqueous methanol (5% H2O by
volume) and irradiated for 4 h. The mixture was then concentrated and purified via flash
chromatography. 0.25 g (81%). 1H NMR (500 MHz, CDCl3) δ 7.45-7.30 (m, 8H), 7.167.12 (m, 1H), 6.23 (dd, J = 6.1, 1.8 Hz, 1H), 5.95 (d, J = 6.0, Hz, 1H), 5.05 (dd, J = 1.6,
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Hz, 1H), 4.97 (d, J = 14.5 Hz, 1H), 4.54 (d, J = 14.5 Hz, 1H), 4.34 (d, J = 18.4 Hz, 1H),
4.09 (d, J = 18.4 Hz, 1H), 3.41 (ddd, J = 24.4, 12.4, 6.0 Hz, 2H), 2.11-2.03 (m, 1H), 1.851.69 (m, 4H), 1.62-1.52 (m, 1H).

3-(2-aminophenyl)-1-methyl-5,6-dihydropyrazin-2(1H)-one (28c): 0.34
g isatin (2.31 mmol), 0.17 g N-methylethylenediamine (2.31 mmol), and a large excess of
anhydrous magnesium sulfate (2.78 g, 10 equiv) were stirred in freshly distilled THF at
ambient temperature for 1 h. The solution was filtered to remove magnesium sulfate,
concentrated, and purified on silica gel via flash chromatography to give 0.11 g of the
pure product (24%). 1H NMR (500 MHz, CDCl3) δ 7.76 (dd, J = 8.3, 1.5, 1H), 7.17 (dt, J
= 7.5, 7.5, 1.5, 1H), 6.75-6.67 (m, 2H), 5.78 (br. s, 2H), 3.94 (t, J = 6.3, 2H), 3.52 (t, J =
6.3, 2H), 3.17 (s, 3H).

13

C NMR (126 MHz, CDCl3) δ 163.8, 157.2, 148.2, 132.4, 131.0,

117.0, 116.7, 116.2, 47.0, 46.3, 34.9.

3-(furan-2-yl)-N-(2-(4-methyl-3-oxo-3,4,5,6-tetrahydropyrazin2-yl)phenyl)propanamide (29c): 0.12 g of the 28c (0.59 mmol), 0.11 g of 17c (0.69
mmol, 1.2 eq), and 0.08 g triethylamine (0.83 mmol, 1.4 eq) were stirred at ambient
temperature in freshly distilled THF (20 mL) for 2 h. The solvent was then removed, the
residue dissolved in ethyl acetate (25 mL), and washed with saturated sodium bicarbonate
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(2 x 15 mL) and brine (1 x 15 mL). The organic layers were combined and dried over
anhydrous sodium sulfate, concentrated, and purified via silica gel chromatography to
give 0.14 g of the product (78%). 1H NMR (500 MHz, CDCl3) δ 11.34 (br. s, 1H), 8.48
(d=, J = 7.7, 1H), 7.76 (d, J = 8.0, 1H), 7.43 (dt, J = 7.6, 7.6, 1.5, 1H), 7.33 (d, J = 2.0,
1H), 7.12 (t, J = 7.6, 1H), 6.30 (dd, J = 3.1, 2.0, 1H), 6.08 (d, J = 3.1, 1H), 3.98 (t, J =
6.1, 2H), 3.56 (t, J = 6.1, 2H), 3.19 (s, 3H), 3.09 (t, J = 7.4, 2H), 2.70 (t, J = 7.4, 2H).

13

C

NMR (126 MHz, CDCl3) δ 170.8, 170.1, 164.0, 156.6, 154.5, 151.1, 138.5, 131.9, 131.3,
122.5, 121.6, 110.3, 105.4, 47.1, 46.1, 36.6, 35.0, 23.9.

(2'RS,31SR,6aSR)-1'-methyl-2,3,4',5'-tetrahydro-1'H-spiro[furo[2,3b]pyrrolo[1,2-a]quinoline-7,2'-pyrimidine]-1,6'(3'H,6aH)-dione (30c): 0.12 g of 29c
(0.37 mmol) was dissolved in aqueous methanol (5% water by volume), and irradiated in
a Pyrex reaction vessel in a Rayonet reactor equipped with RPR-3500 UV lamps
(broadband 300-400 nm UV source with peak emission at 350 nm) for 36 h. After flash
chromatography purification on silica gel using a gradient of 0%-100% ethyl acetate in
hexanes, the pure product was recovered. 41 mg (35%). 1H NMR (500 MHz, CDCl3) δ
7.84 (dd, J = 8.0, 1.1, 1H), 7.38 (dt, J = 8.0, 1.3, 1H), 7.18 (dt, J = 7.7, 1.1, 1H), 7.12 (dd,
J = 7.7, 1.3, 1H), 6.20 (t, J = 2.8, 1H), 5.43 (dd, J = 2.8, 2.3, 1H), 3.91 (t, J = 2.8, 1H),
3.54 (dd, J = 12.0, 8.8, 4.9, 1H), 3.31 (dt, J = 12.0, 4.5, 1H), 3.14 (s, 3H), 2.97-2.87 (m,
2H), 2.81 (ddd, J = 13.3, 8.8, 4.4, 1H), 2.67 (dd, J = 9.1, 1H), 2.64-2.51 (m, 2H), 2.44102

2.36 (m, 1H).

13

C NMR (126 MHz, CDCl3) δ 167.8, 144.7, 133.3, 131.6, 128.6, 128.0,

125.4, 123.5, 101.8, 100.8, 64.4, 58.5, 50.8, 38.5, 35.6, 35.3, 29.8.

(2'RS,3aSR,Z)-1'-methyl-3a,6-oxa-3,3a,4',5'-tetrahydro-1H,1'Hspiro[benzo[g]pyrrolo[1,2-a]azocine-7,2'-pyrimidine]-1,6'(2H,3'H,6H)-dione

(31c):

0.12 g of 29c (0.37 mmol) was dissolved in aqueous methanol (5% water by volume),
and irradiated in a Pyrex reaction vessel in a Rayonet reactor equipped with RPR-3500
UV lamps (broadband 300-400 nm UV source with peak emission at 350 nm) for 36 h.
After flash chromatography purification on silica gel using a gradient of 0%-100% ethyl
acetate in hexanes, the pure product was recovered. 47 mg (39%). 1H NMR (500 MHz,
CDCl3) δ 7.44 (dd, J = 8.0, 1.4, 1H), 7.33 (dt, J = 7.7, 1.5, 1H), 7.17 (dt, J = 8.0, 1.5, 1H),
6.97 (dd, J = 7.7, 1.4, 1H), 6.83 (dd, J = 5.7, 2.0, 1H), 5.67 (dd, J = 5.7, 1.0, 1H), 4.82
(dd, J = 1.9, 1.0, 1H), 3.61 (ddd, J = 11.4, 11.4, 5.6 1H), 3.22 (ddd, J = 11.4, 4.2, 1.2,
1H), 3.13 (s, 3H), 2.97 (dt, , J = 17.6, 9.5, 1H), 2.85 (ddd, J = 12.5, 5.4, 1.2, 1H), 2.77
(ddd, J = 12.1, 12.1, 4.2, 1H), 2.72-2.67 (m, 2H), 2.59-2.42 (m, 2H).

13

C NMR (126

MHz, CDCl3) δ 173.1, 169.2, 168.2, 139.4, 133.6, 130.4, 128.8, 128.0, 127.8, 125.6,
103.7, 86.0, 73.1, 50.2, 37.9, 34.7, 30.4, 28.8.
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Chapter 5: Conclusions and Summary
With the techniques and methodologies described in this research, we have been
able to demonstrate the rapid growth in molecular complexity that excited state chemistry
offers by providing expeditious access to a topologically diverse range of diverse
polycyclic structures, many of which are decorated with rigidly held functional groups.
Such small, drug-like molecules are thought by many to be desirable in their function as
molecular probes for exploring unknown binding pockets in proteins,17 and are on point
with Schreiber’s assertion that diversity-oriented syntheses and targets with a high level
of molecular complexity are highly desirable for the exploration of biological and
medicinal applications.18 With these heretofore underutilized techniques in the “synthetic
toolbox” and the potential for various diversity inputs at many of the steps, it is our hope
that these compounds and methods have a broader impact on medicinal chemistry and
drug discovery.
To this end, we have probed the potential of how strain installed via a
photochemical step can exact surprising rearrangements to give novel scaffolds. We also
showed how adjusting the flexibility of a starting material can change the regiochemistry
of a photochemical step as well as the topology of the products resulting from
oxametathesis. We have also developed a modular assembly of compounds which can
give rise to azaxyxylenes via ESIPT and which can undergo cycloaddition with tethered
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unsaturated pendants. This assembly scheme is rich in potential for a variety of diversity
inputs, a few of which are explored in this research.
Since our goal is the synthesis of polyheterocyclic drug-like scaffolds, several of
the compounds listed in this work have been subjected to quick screening via OSIRIS
Property Explorer,53 a program that has a proprietary algorithm for assessing a variety of
characteristics of a given structure. This program estimates a molecule’s LogP or the
partition coefficient for log(coctanol/cwater). This calculated LogP, or cLogP provides insight
into how hydrophilic a compound is. Compounds with a high LogP are thought to have
poor absorption/permeation as drugs. According to Lipinski’s rule of 5,54 this value
should be less than 5. Tangential to this absorption calculation is the LogS value which
is a second assessment of solubility. It is desirable to have a value greater than -4 in this
category. Another value given is its druglikeness. This is assessed by comparing
topological fragments within a given molecule to a database of common “fingerprint”
fragments within existing drugs. Ideally, this value should be positive. Lastly is drugscore—a parameter that combines these and other features of a given compound
(including Lipinski’s rule that molecular weight should be less than 500 g/mol). This
value ranges from 0-1.0, with 1.0 being the better potential drug lead.
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Figure 5.1: OSIRIS assessment of compounds
The focus on this research was in the methods—the implementation of various
synthetic schemes which include photochemical techniques and furnishing unique,
privileged polycyclic and polyheterocyclic scaffolds. It is promising that the products
themselves hold the potential to be drug leads. With the methods described herein, we
hope to have advanced the practical application of photoassisted syntheses in the DOSapproach to novel drug-like polyheterocycles.
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Appendix A: NMR spectra for Chapter 3
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Appendix B: NMR Spectra for Chapter 4
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